University of New Hampshire

University of New Hampshire Scholars' Repository
Doctoral Dissertations

Student Scholarship

Winter 2007

Development and application of methods for analysis of fungal
glycosphingolipid structure and functional interactions
Emma Adhiambo Arigi
University of New Hampshire, Durham

Follow this and additional works at: https://scholars.unh.edu/dissertation

Recommended Citation
Arigi, Emma Adhiambo, "Development and application of methods for analysis of fungal glycosphingolipid
structure and functional interactions" (2007). Doctoral Dissertations. 407.
https://scholars.unh.edu/dissertation/407

This Dissertation is brought to you for free and open access by the Student Scholarship at University of New
Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized
administrator of University of New Hampshire Scholars' Repository. For more information, please contact
Scholarly.Communication@unh.edu.

DEVELOPMENT AND APPLICATION OF METHODS FOR ANALYSIS OF
FUNGAL GLYCOSPHINGOLIPID STRUCTURE AND FUNCTIONAL
INTERACTIONS

BY

EMMA ADHIAMBO ARIGI
BS, Egerton University, Kenya 2001

DISSERTATION

Submitted to the University of New Hampshire
in Partial Fulfillment of
the Requirements for the Degree of

Doctor of Philosophy
in
Chemistry

December, 2007

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

UMI N um ber: 3290100

INFORMATION TO USERS

The quality of this reproduction is dependent upon the quality of the copy
submitted. Broken or indistinct print, colored or poor quality illustrations and
photographs, print bleed-through, substandard margins, and improper
alignment can adversely affect reproduction.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted. Also, if unauthorized
copyright material had to be removed, a note will indicate the deletion.

®

UMI
UMI Microform 3290100
Copyright 2008 by ProQuest Information and Learning Company.
All rights reserved. This microform edition is protected against
unauthorized copying under Title 17, United States Code.

ProQuest Information and Learning Company
300 North Zeeb Road
P.O. Box 1346
Ann Arbor, Ml 48106-1346

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

This dissertation has been examined and approved.

^

.

—
1
_ -----------------------------------------------Dissertation Director, Steyeh B. Levery, Associate
Professor Chemistry

%. i
W. Rudolf Seitz, Professor Chemistry

,,

?S .

_______

Roy P. Planalp, Associate Professor Chemistry

Arthur Greenberg, Professor Chemistry
/'I
Anita S. Klein, Associate Professor Biochemistry and
Molecular Biology

(3

jX ^ e - g .^ 4 b - G / t '2 'O P ?

Date

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

DEDICATION
To my mum Florence and my dad Oliver.

iii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ACKNOWLEDGEMENTS
My sincerest gratitude goes out to all the wonderful and talented
individuals who made a significant contribution to my academic development and
success. To my research advisor Prof. Steven Levery for your guidance,
patience and support and members of the Levery group especially Beau Bennion
and Yunsen Li.
Special thanks to the Department of Chemistry University of New
Hampshire for granting me the opportunity and providing the support necessary
for me to pursue my graduate work. I wish to thank Analytical Chemistry Faculty
(Prof. Seitz and Prof. Tomellini), my dissertation committee, departmental staff
(Cindi Rohwer and Peg Torch, Kristin McFarlane), and Kathy Gallagher from the
UIC. I am grateful to Prof.Vernon Reinhold for the use of the MS facility and the
members of the Reinhold group (Hui and David) for offering help with the
instruments.
Faustin I really appreciate your support, encouragement and suggestions.
Prof. Henrik Clausen and the wonderful team at University of Copenhagen,
Denmark (Hans, Mads and Katrine) I am especially grateful for your generosity,
and help with my final project.
To my wonderful family (dad, mum, Linda, John, Elly and Mike), you are
the best. To the friends I made at NH (Jis Joe, Elizabeth Mello, Kathryn Ornell,
Karelle Aiken), I love you all.

IV

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

TABLE OF CONTENTS
DEDICATION.................................................................................................................Hi
ACKNOWLEDGEMENTS............................................................................................ iv
LIST OF TABLES.......................................................................................................... vii
LIST OF FIG U R E S ......................................................................................................viii
LIST OF SCHEMES....................................................................................................xiv
ABSTRACT.........................................................:.......................................................xvii

CHAPTER
I.

PAGE

INTRODUCTION.......................................................................................... 1
Background and Significance.................................................................... 1

II.

CHARACTERIZATION OF GLYCOSPHINGOLIPIDS
FROM FUNGI............................................................................................. 18
Characterization of Neutral and Acidic Glycosphingolipids from the
Lectin-producing Mushroom, Polyporus squamosus............................. 18
Materials and Experimental Methods................................................... 21
Results........................................................................................................25
Discussion...................................................................................................40
Characterization of Glycosphingolipids from the Mushroom Coprinus
cinereus........................................................................................................42
Experimental Materials and

Methods....................................................43

Results and Discussion..............................................................................45
III.

MSn ANALYSIS OF PERMETHYLATED
GLYCOSYLINOSITOLS............................................................................ 52

v

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Introduction................................................................................................. 52
Experimental Methods...............................................................................54
Results and Discussion............................................................................. 55
IV.

METHOD DEVELO PM EN T..................................................................... 77
Introduction................................................................................................. 77
Experimental Materials and Methods...................................................... 81
Results......................................................................................................... 83
Discussion................................................................................................... 97

V.

DEVELOPMENT OF GLYCOSPHINGOLIPID BASED GLYCAN
MICROARRAYS.........................................................................................99
Introduction................................................................................................. 99
Experimental Materials and Methods.................................................... 101
Results and Discussion...........................................................................104
Conclusions and Future Studies............................................................ 107

REFERENCES.....................................................................................................109
APPENDICES

............................................................................................ 118

APPENDIX A. SPHINGOLIPID BIOSYNTHETIC PATHWAY........................119
APPENDIX B. COMPOSITION ANALYSIS OF FATTY ACID AND
SPHINGOID BASE BY GC/MS................................................121
APPENDIX C. GLYCOSYL LINKAGE ANALYSIS OF PARTIALLY
METHYLATED ALDITOL ACETATES (PMAAS) BY
GC/MS......................................................................................... 129
APPENDIX D. Coprinus cinereus SUPPLEMENTARY DATA...................... 142
APPENDIX E. PERMETHYLATED GLYCOSYLINOSITOLS
SUPPLEMENTARY DATA.......................................................147
APPENDIX F. CHAPTER IV SUPPLEMENTARY DATA............................... 149

vi

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LIST OF TABLES

Title

Page

2.1

Molecular adduct ions [M(Li)+Li]+ observed in
ESI-Q/-TOF-MS

36

2.2

Glycosylinositol- and phosphorylglycosylinositol-related
product ions formed in low energy
ESI-MS/CID-TOF-MS spectra

37

2.3

Molecular adduct ions [M(Li)+Li]+ observed in
ESI-MS profile of C. cinereus

51

2.4

Glycosylinositol ions from ESI-MS spectra of
monoglycosylinositol phosphoryceramides from fruiting
body of C. cinereus

51

B.1

Interpretation of ions from GC-MS analysis of fatty acid
methyl esters

125

v ii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LIST OF FIGURES
Title

Page

1.1

Representative structure of a classical GSL ((3-D-galactosylceramide)

1.2

Structures of sphingoid bases: (A) sphingosine and (B)
phytosphingosine.

1.3

Summary of pathways for lysosomal degradation of sphingolipids

6

Structures of fungal cerebrosides

8

1

.4

1
3

1.5

Representative fungal GIPC structure (amannosylinositolphosphorylceramide)

2.1

Positive ion ESI-Qq/oa-TOF-MS of Fr 27-30 (Ps-1)

29

2.2

Positive ion ESI-Qq/oa-TOF-MS of Fr 31 (Ps-2)

31

2.3

Positive ion ESI-Qq/oa-TOF-MS of Fr 33-34 (Ps-5)

34

2.4

Positive ion ESI-MSn analysis of purified GlcCer
from P. squamosus

39

2.5

HPTLC (orcinol stain) of neutral lipids from C.cinereus

46

2.6

HPTLC (orcinol stain) of GIPCs from C.cinereus

46

2.7

Molecular ion profile of Fr 29 as Li adducts. B: MS 2 of
m/z 1100 and C: MS2 of m/z 1128

48

2.8

A: Molecular ion profile of Fr 30 as Li adducts. B: MS2 of
m/z 1072 and C: MS 2 of m/z 1086

49

2.9

A: Molecular ion profile of Fr 31 as Li adducts. B: MS2 of
m/z 988 and C: MS 2 of m/z 1016

50

3.1

Positive ion mode MS 1 profile of permethylated
diglycosylinositol from A.A.fumigatus GIPC Maned-»3Mana2IPC
and B: P.squamosus GIPC Gal|31—>6Mana2IPC

56

3.2

Positive ion mode ESI-MSn of permethylated diglycosylinositol from

v iii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

9

57

P.squamosus GIPC Gaipi —>6Mana2IPC. A: MS 2 product ion spectrum
m/z 695 —> and B: MS 3 product ion spectrum m/z 695 —> m/z 445 —>
3.3

Positive ion mode ESI-MSn of permethylated diglycosylinositol from
59
A.fumigatus GIPC Maned—>3Mana2IPC. A: MS product ion spectrum m/z
695 —» and B: MS 3 product ion spectrum m/z 695 —►m/z 445 —>

3.4

Positive ion mode MS 1 profile of permethylated triglycosylinositol
62
from A: A.nidulans GIPC Mana3(Mana6)Mana2IPC and B: A.fumigatus
GIPC Maned—>2Mancd-»3Mana2IPC

3.5

Positive ion mode ESI-MSn of permethylated triglycosylinositol from
63
A.fumigatus GIPC M a n al—>2Mana1—>3Mana2IPC. A: MS 2 product ion
spectrum m/z 899
B: MS 3 product ion spectrum m/z 899 -» m/z 649 —>
and C: MS 4 product ion spectrum m/z 899 —►m/z 649 —> m/z 445 —►

3.6

Positive ion mode ESI-MSn of permethylated triglycosylinositol from
65
A.nidulans GIPC Mana3(Mana6)Mana2IPC. A: MS 2 product ion spectrum
m/z 899
B: MS 3 product ion spectrum m/z 899 —►m/z 649 —»•

3.7

Positive ion mode ESI-MSn of permethylated pentaglycosylinositol from 6 8
A.bisporus GIPC Galcd—>6Gala1— > 6 (Fuccd —»2)Gal|31—>6Mana2IPC. A:
MS2 product ion spectrum m/z 1277 —*■and B: MS 3 product ion spectrum
m/z 1277—►m/z 1 0 2 7 ^

3.8

Positive ion mode ESI-MSn of permethylated pentaglycosylinositol from 70
C.neoformans GIPC Maned—^ (X y ip i—>2) Maned-»4Gal(31—>6Mana2IPC
A: MS2 product ion spectrum m/z 1263 —> and B: MS 3 product ion spectrum
m/z 1263 —> m/z 1013 —►

3.9

Positive ion mode ESI-MSn of permethylated hexaglycosylinositol from 73
C.neoformans GIPC
Maned—►6Mana1—>3(Xyipi—>2)Mancd —>4Gaipi—>6Mana2IPC. A: MS 2
product ion spectrum m/z 1467 —►and B: MS 3 product ion spectrum m/z
1467 —*■m/z1217—►

3.10

4.1

Positive ion mode ESI-MSn of permethylated hexaglycosylinositol from 75
C.neoformans GIPC
Maned^6Mana1->3(Xylf31-+2)Mana1^4Galf31-+6Mana2IPC. A: MS 4
product ion spectrum m/z 1467 -*• m/z 809 —»• m/z 635—►and B: MS 5
product ion spectrum m/z 1467 —►m/z 809 —►m/z 635—►m/z 445 -+
Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS 2
analysis (B) of /V-deacylated GIPC (Mana2IPC) F-|7 -Cbz-OSu-tagged
derivative from P. squamosus (Ps-1)

ix

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

84

4.2

Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS 2
85
analysis (B) of /V-deacylated GIPC (Gal(36Mana2IPC) Fi 7 -Cbz-OSu-tagged
derivative from P. squamosus (Ps-2)

4.3 (A). HPTLC profile (silica gel 60, CHCI3 -MeOH-water, 50:40:10 v/v/v +
8 6
0.03% CaCI2) of BI-3 from A.bisporus. Lane 1, Mana2IPC, Lane 2 Decane
layer, Lane 3 A/-deacylated GIPC (lower band). The marked band (*) does
not correspond to a GIPC. (B). HPTLC profile (silica gel 60,
CHCI3 - MeOH-water, 50:40:10 v/v/v + 0.03% CaCI2) of BI-3 from
A.bisporus. Lane 1 A/-deacylated BI-3, Lane 2 and 3 F17-derivatized BI-3
following F-SPE clean up. Fractions eluted in 80%v/v MeOH-water and
100% MeOH respectively
4.4

Positive ion mode analysis ESI-LTQ-MS 2 1978—> (A) and (B) MS 3
87
1978—>1832—> (analysis of A/-deacylated GIPC
Galpa6Galpa6[Fucpa2]Gal|36Mana2IPC) Fi 7 -Cbz-OSu-tagged derivative
following F-SPE

4.5

(A) MS 3 (m/z 1978^1424 ->), (B) MS 4 (m/z 1978-^1424 -»1278->)
89
and (C) MS 5 (m/z 978—>1424 —>1278 —>935—>) product ion spectra of
A/-deacylated GIPC (Galpa 6 Galpa6[Fucpa2]Gal|36Mana2IPC) F 17 -CbzOSu-tagged derivative

4.6

Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS 2
analysis of N-deacylated mannosyl-IPC (Mana2IPC) F-Fmoc-tagged
derivative (B and C) following F-SPE

91

4.7

Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS 2
analysis of A/-deacylated dimannosyl-IPC (Mana3Mana2IPC) F-Fmoctagged derivative (B and C) following F-SPE

92

4.8

HPTLC profile (silica gel 60, CHCI3 -MeOH-water,
93
50:40:10 v/v/v + 0.03% CaCI2) of lyso-GM1 lane 1 and N HS-PE0 2 -2-MEA
derivatized lyso-GM1 lane 2 after C-18 SPE clean-up, sample eluted with
100% MeOH

4.9

A. MALDI-MS spectrum of lyso-GM1 B. lyso-GM1-PE02-maleimide
derivative and C. Lyso-GM1-PE0 2 -maleimide-2-MEA derivative

5.1

Fluorescence images of GSLs arrayed on an NHS-slide.
106
Columns of 5 spots each ~ 100, 50, 25, 12.5 and 6.25 uM
incubated with cholera toxin B (recombinant) Alexa Fluor 555 conjugate
(A) and biotin labeled PNA lectin-streptavidin DyLight™ 547conjugate
(B)

5.2

Fluorescence images of GSLs arrayed on a fluorous slide.

x

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

94

107

Columns of 3 spots each ~ 100, 50 and 25 pM incubated with cholera toxin
B (recombinant) Alexa Fluor 555 conjugate (A) and 5pg/mL of biotin
labeled PNA lectin-streptavidin DyLight 547 conjugate (B)
A.1

Sphingolipid biosynthesis in animals and fungi

120

B.1

Partial total ion chromatogram of FAME and sphingoid component
analysis

122

B.2

Mass spectrum of h22:0 FAME derivative

123

B.3

Mass spectrum of h23:0 FAME derivative

123

B.4

Mass spectrum of h24:0 FAME derivative

124

B.5

Mass spectrum of A/-acetyl-1,3,4-tri-O-trimethylsilyl
t18:0 4-hydroxysphinganine

124

B. 6

Chromatogram of dihydroxy fatty acid (dh24:0)FAME

125

B.7

Mass spectrum of dh24:0 FAME derivative

126

B. 8

Partial ion chromatogram of erythro form of 2,3-dihydroxy palmitic
acid (d16:0)

126

B.9

B.10

Mass spectrum of erythro form of dh16:0 FAME derivative

Partial ion chromatogram of threo form of 2,3-dihydroxy palmitic
acid (d16:0)

B.11 Mass spectrum of threo form of dh16:0 FAME derivative

127

127

128

C.1

(A) Chromatogram of FAME
derivatized Ps-1 and (B) Mass spectrum131
of 1,5-di-0-acetyl-1 -deuterio-2,3,4,6-tetra-0-methyl-mannitol

C.2

(A) Chromatogram of FAME
derivatized Ps-2 and (B) Mass spectrum133
of 1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl-mannitol

C.3

C.4

Mass spectra (A) of 1,5-di-O-acetyl-1-deuterio-2,3,4,6-tetra-0-methylgalactitol and (B) of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tetra-0-methylmannitol

134

(A) Chromatogram of FAME
derivatized Ps-5 and (B) Mass spectrum136
of 1,3,5-tri-0-acetyl-1 -deuterio-6-deoxy-2,4-di-0-methyl-galactitol

xi

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

C.5 Mass spectra (A) of 1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl138
mannitol and (B) of 1,2,5-tri-0-acetyl-1-deuterio-3,4,6-tri-0-methyl-galactitol
C.7 Mass spectra (A) of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tetra-0-methylmannitol and (B) of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tetra-0-methylgalactitol

140

D.1 HPTLC analysis of GIPC fruiting body fractions isolated from
C.cinereus corresponding to lanes 1-3 (fractions 29-31) from HPLC

143

D.2 A, B and C, downfield expansions (4.00-5.60 ppm) of 1-D 1 H-NMR
144
spectra (500MHz; DMSO-c/6 2%D 2 0 ; 35°C) of GIPC fruiting body fractions
isolated from C.cinereus; spectra acquired on fractions corresponding to
lanes 1-3 (fractions 29-31) from HPLC C.cinereus (40 X 2ml fractions
collected at 0.5ml/min); Lane C, crude GIPC fraction
D.3 MS 3 analysis of fraction 30: Panel A, m/z 1072—>662—►and
Panel B, m/z 1086—»676—►

145

D.4 HPTLC (orcinol stain) of GIPCs from C.cinereus. Mobile phase
146
chloroform-methanol-water (50:47:14 v/v/v) containing 0.038% w/v CaCI2.
Lane C, GIPC standard containing Mana2IPC (MIPC), Lane 1-4 crude acidic
fractions from C.cinereus mycelia
D.5 HPTLC (orcinol stain) of neutral lipids from C.cinereus mycelia. Mobile
phase chloroform-methanol-water (60:30:5 v/v/v). Lane S, standard
containing GlcCer

146

E.1 Positive ion mode ESI-MSn of permethylated pentaglycosylinositol from 148
C.neoformans GIPC Mana1-»3(Xylp1—>2) M a n a l—>4Galf31—>6Mana2IPC
E.2 Positive ion mode ESI-MS" of permethylated hexaglycosylinositol from
C.neoformans GIPC Maned-»6Mana1—>3
(Xyipi —>2)Mana1 -»4Gal|31 —»6Mana2IPC
F.1

148

HPTLC profile (silica gel 60, CHCI3 -MeOH-water, 50:40:10 v/v/v
150
+ 0.03% CaCI2) of MIPC from A.bisporus. Lanes S, Mana2IPC, Lanes 1 and
3 A/-deacylated MIPC (lower band). Lanes 2 and 4 decane layer

F.2 HPTLC profile (silica gel 60, CHCh-MeOH-water, 50:40:10 v/v/v
150
+ 0.03% CaCI2) of dimannosyllPC (Af-2) from A.fumigatus. Lanes S,
Mana3Mana2IPC, Lanes 1 and 3 A/-deacylated Af-2 (lower band). Lanes 2
and 4 decane layer
F.3 HPTLC profile (silica gel 60, CHCh-MeOH-water, 50:40:10 v/v/v
151
+ 0.03% CaCI2) of lyso-GM1 lanel and Fu-Cbz-OSu derivatized lyso-GM1

x ii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

lanes 2 and 3
F.4

HPTLC profile (silica gel 60, CHCI3 -MeOH-water, 50:40:10 v/v/v
+ 0.03%CaCI2) of psychosine lanel and Fi 7 -Cbz-OSu derivatized
psychosine lanes 2-5.

F.5

HPTLC profile (silica gel 60, CHCI3 -MeOH-water, 50:40:10 v/v/v
152
+ 0.03% CaCI2) of F-Fmoc derivatized lyso-GM1(40ug) lane 1 and lysoGM1 standard lane 2

F. 6

HPTLC profile (silica gel 60, CHCI3 -MeOH-water, 50:40:10 v/v/v
153
+ 0.03% CaCI2) of F-Fmoc derivatized lyso-GM1following F-SPE clean up.
Fractions eluted in 40% v/v MeOH-H20 (Lanesland 2), 60% MeOH- H20
(lanes 3and 4), 80%v/v MeOH- H20 (lanes 5and 6 ), and 100% MeOH (lanes
7and 8 ). Lane S is lyso-GM1 standard

x iii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

151

LIST OF SCHEM ES
Title

Page

1.1

Mammalian GSL biosynthetic pathway

1.2

Biosynthesis of fungal GIPCs

11

2.1

Biosynthesis of fungal GIPCs starting with transfer
of myo-inositol-1-O- phosphate (IP) from diacylglycerol
(DAG) moiety of phosphatidylinositol to ceramides

20

2.2

Characteristic fragmentations of glycosylated IPCs

5

25

2.3

Fragmentation of GIPC Ps-1 in positive ion ESI-Qq/oa-TOF-MS

30

2.4

Fragmentation of GIPC Ps-2 in positive ion
ESI-Qq/oa-TOF-MS

32

2.5

Fragmentation of GIPC Ps-5 in positive ion
ESI-Qq/oa-TOF-MS

35

2.6
2.7.

Structure of prototypical fungal glucosylceramide
Fungal lipid extraction, fractionation and purification

40
44

3.1

Nomenclature of major fragment sugar ions

53

3.2

Fragmentation of m/z 695 ion produced by positive ion mode MS 2
and of m/z 445 ion produced by positive ion mode MS 3 of
permethylated diglycosylinositol Gal(36Mana2lns

58

3.3

Fragmentation of m/z 695 ion produced by positive ion mode MS 2
and of m/z 445 ion produced by positive ion mode MS 3 of
permethylated diglycosylinositol Mana3Mana2lns

60

3.4

Positive ion mode fragmentation of m/z 899 ion produced by
MS2, m/z 649 ion produced by MS3, and m/z 445 ion
produced by MS4 of permethylated triglycosylinositol Mana3
Mana2Mana2lns

64

3.5

Positive ion mode fragmentation of m/z 899 ion produced by MS2,
and m/z 649 ion produced by MS 3 of permethylated triglycosylinositol

66

x iv

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Mana3(Mana6)Mana2lns
3.6

Fragmentation of m/z 1277 ion produced by positive ion mode
MS and of m/z 1027 ion produced by positive ion mode MS 3 of
permethylated pentaglycosylinositol
G a la l—>6Gala1 - » 6 (Fucal->2)Galp1 ^6M ana2IPC

3.7

Fragmentation of m/z 1263 and m/z 1089 ion produced by
positive ion mode MS 2 and of m/z 1013 ion produced by positive ion
mode MS 3 of permethylated pentaglycosylinositol
Man1 ->3(Xylf31 —>2)Man1 —>4Gal|31 -+6Mana2IPC

71

3.8

Fragmentation of m/z 1467 ion produced by positive ion mode
MS2 and of m/z 1217 ion produced by positive ion mode MS 3 of
permethylated hexaglycosylinositol
Manal —>6Man1 —>3(Xylp1 —»2)Man1 —>4Gal(31 —>6Mana2IPC

74

3.9

Fragmentation of m/z 635 ion produced by positive ion mode MS 4
76
and of m/z 445 ion produced by positive ion mode MS 5 of permethylated
hexaglycosylinositol Manal —>6Mana1 —>3
(Xyipi —>2)Man1 —»4Gal(31 -»6Mana2IPC

4.1

Reaction of mannosyl IPC from with sphingolipid
ceramide-A/-deacylase (SCDase) and susbsequent F-tagging
with F-Cbz-OSu

78

4.2

Reaction of mannosyl IPC from A. bisporus with
sphingolipid ceramide-A/-deacylase (SCDase) and
susbsequent F-tagging with F-Fmoc

79

4.3

Reaction of Galactosylsphingosine (GalSph) with
NHS-PE02-maleimide and subsequent tagging with 2-MEA

80

4.4

Fragmentation scheme of F-17-Cbz-OSu -derivatized
BI-3 from A.bisporus

4.5

Structure of the expected product of the reaction of
lyso-GM1 with NHS-PE 0 2 -maleimide

95

4.6

Structure of the expected product of the reaction of
lyso-GM1 -NHS-PE 0 2 -maleimide derivative with 2-MEA

96

5.1

Immobilization of fluorocarbon- and NHS-PE02-maleimidetagged lyso- GM1 and interaction with carbohydrate binding
proteins of interest

XV

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

69

8 8

101

C.1

Summary of the steps leading to formation of PMAAs

130

C.2

Characteristic fragmentation of 1,5-di-0-acetyl-1 -deuterio-2,3,4,6
-tetra-O-methyl-mannitol

132

C.3

Characteristic fragmentation of 1,5-di-0-acetyl-1 -deuterio-2,3,4,6
-tetra-O-methyl-galactitol

135

C.4

Characteristic fragmentation of 1,5,6-tri-0-acetyl-1 -deuterio
-2,3,4-tetra-O-methyl-mannitol

135

C.5

Characteristic fragmentation of 1,3,5-tri-0-acetyl-1 -deuterio
-6-deoxy-2,4-di-0-methyl-galactitol

137

C.6

Characteristic fragmentation of 1,2,5-tri-0-acetyl-1 -deuterio
-3,4,6-tri-O-methyl-galactitol

139

C.7

Characteristic fragmentation of 1,5,6-tri-0-acetyl-1 -deuterio
-2,3,4-tetra-O-methyl-galactitol

141

xvi

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ABSTRACT
APPLICATION AND DEVELOPMENT OF METHODS FOR ANALYSIS OF
FUNGAL GLYCOSPHINGOLIPID STRUCTURE AND FUNCTIONAL
INTERACTIONS
by
Emma Adhiambo Arigi
University of New Hampshire, December, 2007
Fungal lectins from the mushrooms Polyporus squamosus and Coprinus
cinereus have an affinity for (3-galactosides, with extended binding sites for the
non-reducing terminal trisaccharide sequence NeuAca2—►6Galp1—>4Glc/GlcNAc,
and substituted P-galactosides resembling mammalian blood group
determinants, respectively. In considering the possibility that glycosylinositol
phosphorylceramides (GIPCs) could be endogenous ligands of such fungal
lectins, structural characterization of glycosphingolipids (GSLs) from the fruiting
bodies of these mushrooms was performed. The extraction, isolation and
purification of the lipids, and their subsequent characterization by nuclear
magnetic resonance (NMR), mass spectrometry (MS) and gas chromatographymass spectrometry (GC-MS) was performed. One monohexosylceramide (CMH)
and three major GIPCs were identified from P. squamosus. The GIPCs were
identified as M a n al—>2lns-P-Cer (Ps-1), Gal[31—>6Mana1—^Ins-P-Cer (Ps-2)
and Manal ->3Fuca1—>2Gala1-*6Gal(31—»6Mana1—>2lns-P-Cer (Ps-5). Of these
GSLs, Ps-2 could be a potential ligand for P.squamosus lectin. From C. cinereus,
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three components were identified as typical fungal Manal —>2lns-P-Cer
incorporating unusually short chained ceramides not previously reported in other
basidiomycetes.
In addition, preliminary studies towards development of high throughput
methods for glycosphingolipidome analysis were performed. These studies
explored (i) the use of MS" for disassembly of permethylated glycosylinositols
(GIs) and (ii) the construction of GSL-based glycan microarrays. MSn analysis of
GIs efficiently provided useful information on linkage and sequence. An essential
step in microarray development involved the enzymatic release of the hydroxyl
fatty acyl of the ceramide moiety of selected fungal GIPCs with sphingolipid Ndeacylase (SCDase). Derivatives were generated from the reaction of the
resulting free amino group with A/-reactive F-tag (A/-[4-(1H,1H,2H,2H
perfluorodecyl)benzyloxycarbonyloxyl]succinimide (Fi 7 -Cbz-OSu, C 2 2 Hi 4 F 1 7 N 0 5),
and with a linker assembled from succinimidyl-[(A/-maleimidopropionamido)diethyleneglycol] ester (NHS-PEC>2 -maleimide) and 2-mercaptoethylamine (2MEA). The derivatives were immobilized via fluorous-flourous affinity, and by
amide bond formation on W-hydroxysuccinimide-activated micro-glass slides,
respectively. Preliminary evaluation of their use in assaying protein-carbohydrate
binding interactions was carried out. The potential utility of this methodology for
designing microarrays that incorporate both mammalian and fungal GSLs for
serodiagnosis is discussed.
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CHAPTER I

INTRODUCTION

Background and Significance

Definition
Glycosphingolipids (GSLs) are a class of natural products that have been
identified as important structural and functional elements critical to the life cycle
of fungi and other eukaryotes. They are present primarily in the plasma
membranes of eukaryotic cells, localized at the outer leaflet of the membrane,
with their hydrophilic sugar chains protruding from the surface. GSLs consist of
one or more monosaccharides linked either directly or indirectly to the primary
hydroxyl of a lipid moiety called ceramide (in general, any A/-acylsphingoid where
sphingoid is any member of a family of 1, 3-dihydroxy-2-amino-alkyls and their
functionalized analogs) (Figure 1.1).
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(R = functionalized hydrocarbon)
Figure 1.1 Representative structure of a classical GSL O-D-galactosylceramide).
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Importance of Glycosphingolipids
Although GSLs are essential for the growth of most eukaryotic organisms,
their precise functional roles are unclear. GSLs are implicated in modulation of
various cellular events including proliferation, differentiation and apoptosis, cell
cell interaction and recognition [1]. GSLs mediate host-pathogen interactions in a
variety of ways. They act as cell surface receptors for viral and bacterial toxins,
as well as carbohydrate binding proteins (lectins) presented on the surface of
microbial cells [2, 3]. In addition, sphingolipid metabolites have been implicated
as key players in cell membrane signal transduction networks and in membrane
trafficking, both of which serve to regulate infection processes such as pathogen
invasion and host defense [4]. A modern view of cell membrane structure and
dynamics holds that surface microdomains called “lipid rafts”, of which GSLs are
a key component, act as platforms for many functional interactions [5, 6 ],
including microbial binding, infection signaling, immunoresponse, and entry of
intracellular parasites [4]. GSLs are also clinically important as ABO and other
blood group antigens, and as indicators of various pathological conditions.
Biosynthesis of Glycosphingolipids
The early steps of sphingolipid biosynthesis are conserved in all
eukaryotes, including mammals and fungi. The structural diversity of
sphingolipids arises at an early stage from expression of a wide variety of
ceramide forms, containing sphingoid bases and fatty acids of variable chain
lengths, degrees of unsaturation, branching and hydroxylation with seemingly

2
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limitless array of polar head group structural variants. Among these, glycans and
modified glycans provide the major source of GSL structural diversity.
In mammals the principal sphingoid base is D-Eryf/tro-sphingosine while
D-R/'bo-phytosphingosine is the principal sphingoid base in Saccharomyces
cerevisiae (Figure 1.2). The corresponding ceramides are referred to as
ceramide and phytoceramide, respectively (Figure A.1).

A

OH

B

OH

Figure 1.2. Structures of sphingoid bases: (A) sphingosine and (B)
phytosphingosine.

In almost all eukaryotes the enzyme glucosylceramide synthase catalyzes
the initial step in a major pathway of GSL biosynthesis, the transfer of glucose
from UDP- glucose to ceramide to form p-glucosylceramide (GlcCer). In
mammals sphingomyelin synthase catalyzes the transfer of phosphorylcholine
from phosphatidylcholine to ceramide to form sphingomyelin (SM). Further
processing of GlcCer by the enzyme (34-galactosyltransferase-T5/T6 to form
lactosylceramide (LacCer; Gal(31—>4Glc(31Cer) initiates the formation of more
complex GSLs classified on the basis of their inner core structures as lacto- (Lc),
neolacto- (nLc), ganglio- (Gg), globo- (Gb), and iso-globo- (iGb) series with the
sequences Gal(31 —>3GlcNAc|31 —>3Gal(31 -»4Glc(31 Cer,
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Galpl -^4GlcNAcpi -^3Gaipi ->4Glcpi Cer,
Galpl ^3GalNAcp1 -+4Galp1 -^4Glcp1 Cer,
GalNAcpi —>3Gala1 —>4Gaipi—>4GlcpiCer, and
GalNAcpi—>3Gala1-»3Galp1—>4GlcpiCer [7] and references therein.
On the other hand, the galactosylation of ceramide in a reaction catalyzed
by galactosylceramide synthase leads to formation of P-galactosylceramide
(GalCer). GalCer is either sulfated by sulfotransferases to form sulfatides such as
galactosylceramide-l3-sulfate (GalCer-3-sulfate), neuraminosylated to form the
ganglioside GM4, or it is further galactosylated to form the gala- and neogalaseries (poly-[a/p-Gal]6 GaipiCer) of GSLs. Other modifications, such as
acetylation are also possible. A summary of the biosynthetic pathways leading to
the formation of major core structures is illustrated in Scheme 1.1. The
distribution of GSLs varies in different tissues and organs, and at different stages
of development even within the same organism or species. For example,
whereas SM and GlcCer are ubiquitiously produced in mammalian tissues, the
expression of GalCer is limited to certain organs such as brain and nerve tissue,
and kidney.

4

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

G aipiC er

Sulfatides

Gala-series

Sulfotransferases
UDP-GalCer synthase
(Gal-T)

Ceramide
Galp3GlcNAcp3Galp4
G lcpiC er
Lacto-series

UDP-GlcCer synthase
(Glc-T)
r

ik

G lcpiC er
Gaip3-T

GlcNAcp3Galp4
G lcpiC er

I
GlcNAcp3-T

Galp4-T

Gal(34-T

G a ip i—»4GlcpiCer
LacCer

Gala3-T,
GalNAc(34-l

Gala4-T,
tGalNAcp4-T

Gaip4GlcNAcp3Galp4
G lcpiC er
Neolacto-series

GalNAcp4-T,
Gaip3-T

Galp3GalNAcp4Galp4
G lcpiC er
Ganglio-series

GalNAcp3Gala3Galp4
G lcpiC er
Isoglobo-series

GalNAcp3Gala4Galp4
G lcpiC er
Globo-series

Scheme 1.1. Mammalian GSLs biosynthetic pathway, Glc-T,
glucosyltransferase; Gal-T, galactosyltransferase; GalNAc-T, Nacetylgalactosamine transferase.

Disruption of the GSL biosynthetic pathway interferes with growth and
development. For example, the complete deletion of the UDP-glucose: ceramide
glucosyltransferase gene (Ugcg) (also called glucosylceramide synthase (GCS))
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in mice caused embryonic lethality; [8 ] cell specific deletion of the same gene in
the brain resulted in neural defects after birth [9], suggesting the importance of
GSLs in embryogenesis and neurological development. On the other hand,
dysfunctional degradation of sphingolipids as a result of a deficiency in one or
more of the degradative enzymes often causes mental retardation and infant
lethality, due to abnormal accumulation of toxic metabolites in tissues. The
inheritable diseases are collectively called sphingolipidoses and include
Niemann-Pick disease, Gaucher’s disease, Krabbe’s disease, metachromatic
leukodystrophy, and several forms of gangliosidoses, such as Tay-Sachs
disease (Figure 1.3).
G mi

nana

-Glc-Gal-GalNAc-Gal
-Gangliosides
NANA
-Glc-Gal-GalNAc
defect = Tay-Sacchs

0-hexosaminidase A

NANA
-Glc-Gal

„

Globosides

,,

.,

a-galactosidase A

-Glc-Gal lactosylceramide -*—2-------------------defect =
Fabry's

0-hexosaminidase \
A and B
j

-Glc-Gal-Gal-GalNAc

glucocerebrosidase | defect = G aucher’s
' * — ^ ^ ^ f i . g a ia c i o s id a s e

sphingomyelinase defect =
Niem ann-Pick

-Pcholine

defect =
SandhofTs

-Glc glucocerebroside

ceramide

-Glc-Gal-Gal

d e fe c tK rabbe's

—

' Gai galactocerebroside

sphingomyelin

Figure 1.3 Summary of pathways for lysosomal degradation of sphingolipids:
Gangliosides Gmi, Gm2 and GM3 , globosides and gluco- and galactocerebrosides.
The structures shown are attached to a ceramide core. Gal, galactose; GalNAc,
/V-acetylgalactosamine; Glc, glucose; NANA, A/-acetylneuraminic acid; Pcholine,
phosphocholine.
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Fungal Glvcosphinqolipids
Two major GSL biosynthetic pathways exist in fungi. The resulting GSLs
are distinguished from each other by the relation of their carbohydrate to the
ceramide moiety. The first group includes “classical” GSLs which have their
sugar portion directly linked to the ceramide by a glycosidic linkage. With the
exception of Saccharomyces cerevisiae, most fungi studied so far express
classical GSLs mainly in the form of monohexosyl ceramides (CMHs) or
cerebrosides, principally glucosylceramides (Glc(31-Cer) and sometimes
galactosylceramides (Gal(31-Cer) as terminal products [10-16]. The function of
Fungal GlcCer synthase gene homologs was first confirmed by Leipelt et al [17].
Fungal cerebrosides differ from mammalian ones by the presence of A 8
unsaturation, and methylation on the C-9 of the sphingoid base, with additional
capability for A3 unsaturation on the fatty acid in some species. The resulting
ceramide component characteristic to these fungal cerebrosides is a 19 carbon
(4£,8E)-9-methyl-4,8-sphingadienine (d19:2) in association with a 2-hydroxy-(E)3-alkenoate or 2-hydroxyalkanoate (Fig 1.4) typically 16 or 18 carbons in chain
length.

7
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19

Figure 1.4 Structures of fungal cerebrosides: (4E,8E)-N-2’-hydroxyoctadecanoyl1(3-D-galactopyranosyl fatty acid A, Ri=H, R2=OH = GalCer A), (4E,8E)-N-2’hydroxyoctadecanoyl-1(3-D-glucopyranosyl fatty acid A, R ^O H , R2=H = GlcCer
A), 4E,8E)-N-2’-hydroxyoctadecanoyl-ip-D-galactopyranosyl fatty acid A, Ri=H,
R2=OH e GalCer B), (4E,8E)-N-2’-hydroxyoctadec(E)-3-enoyl-1(3-Dglucopyranosyl fatty acid A, R ^O H , R2=H = GlcCer B), -9-methyl-4,8sphingadienines, with numbering of sphingosine, hexose and fatty acid moieties.

The disruption of Glc|31-Cer biosynthesis has been found to interfere with
various aspects of fungal growth and development. Forexample, inhibition of
UDP-Glc:ceramide glucosyltransferase encoded by GlcCer synthase (GCS)
genes suppresses spore germination, cell cycle and hyphal development in the
fungi Aspergillus fumigatus and Aspergillus nidulans [18]. GCS has also been
identified as a key virulence factor of Crypotococcus neoformans pathogenicity
by regulating the ability of the fungus to survive in the neutral/alkaline and
physiological C 0 2 environment upon initial colonization of the extracellular space
of the alveoli in the lungs [19]. The presence of anti-CMH antibodies in the sera
of patients with various mycoses suggests that fungal cerebrosides are
immunogenic [15, 20-22], Various studies have shown that anti-CMHs interfered
with cell budding and differentiation [20, 21, 23]. Fungal cerebrosides are

8

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

therefore not only important for their growth and differentiation but also play an
important role in infectivity. However, the mechanism by which they perform their
functions is yet to be established.
The distinguishing feature of the second important class of fungal GSLs is
the possession of an intervening inositol phosphate between the carbohydrate
and the ceramide moiety. The GSLs that incorporate this arrangement are known
as glycosylinositol phosphorylceramides (GIPCs). (Figure 1.5) [24]. The
ceramide moiety in GIPCs is different from that usually found in cerebrosides,
and consists of phytosphingosine (1,3,4-trihydroxysphingosine, also called 4hydroxysphinganine) of 18 or 2 0 carbons in length i.e. t18:0 or t2 0 :0 , in
combination with longer chain saturated 2-hydroxy fatty acids, typically C22, C24
and C26. This implies that fungi maintain two separate pools of ceramides for
GSL synthesis [1,

HO

Na+
or Li

1 0

, 17, 25],

OH

HH OH

Figure 1.5 Representative fungal GIPC structure (a-mannosylinositol
phosphorylceramide).
Biosynthesis of fungal GIPCs begins with the transfer of myo-inositol-1-Ophosphate (IP) from phosphatidyl inositol to the C-1 hydroxy of phytoceramide to
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form inositol-1 -phosphoryl ceramide (IPC), catalyzed by the enzyme inositol
phosphorylceramide (IPC) synthase (encoded by the AUR1 gene, also called
IPC1) [1, 15, 17, 26, 27], In S. cerevisiae the mannosylation of IPC to form
mannosylinositol phosphorylceramide (Mana2IPC, or MIPC) requires the genes
SUR1 and CSG2. In this yeast the terminal step in sphingolipid biosynthesis is
the formation of M(IP)2 C, (IPMIPC) which requires the IPT1 gene [26], IPC1 has
been implicated in the modulation of some virulence factors such as melanin
production of the pathogenic fungus C. neoformans. Research has shown that
the down regulation of the IPC1 gene not only impaired pathogenicity by lowering
melanin but also caused a significant decrease in intracellular growth of
C.neoformans [28].
A similar biosynthetic pathway is proposed for other fungi, but with
diversification leading to other fungal core GIPC structures. The three main core
structures include Ma2IPC, Ma 6 IPC and GlcNa2IPC (where M=Mannose and
GlcN=Glucosamine) [29-36] (Scheme 1.2). These structures act as scaffolds for
further glycosylation by a variety of as yet uncharacterized glycosyltransferases
to yield more complex and structurally diverse GIPCs.
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Scheme 1.2. Biosynthesis of fungal GIPCs, starting with transfer of myo-inositol1-O-phosphate (IP) from diacylglycerol (DAG) moiety of phosphatidylinositol
(IPDAG) to ceramide, catalyzed by AUR1 encoded IPC synthase. The
observation of three intermediate core structures diverging at the
monosaccharide level implies the existence of at least three glycosyltransferases
capable of using IPC as acceptor: (i) Mana2-T (function requires two genes in S.
cerevisiae, SUR1/CSG1 and CSG2), making Mana2IPC; (ii) Mana 6 -T, making
Mana 6 IPC; (iii) GlcNAca2-T, followed by action of de-/V-acetylase, making
GlcNa2IPC. R-i and R2 may be H or OH; R3 and R4 are (CH 2 )nCH 3 with variable
values of n defined by species and other factors.

Further glycosylation of Mana2IPC produces two core structures
apparently characteristic of basidiomycetes and euascomycetes i.e. Gal(316Mana2IPC and Maned-3 Mana2IPC, respectively [29, 32, 34, 37-39]. The
glycosylinositol structural diversity of GIPCs is seen even in closely related
species such as A fumigatus and A. nidulans, suggesting possible functional
roles related to the different glycans expressed [34, 40]. Some GIPCs display
antigenic properties, e.g., the [3-galactofuranosyl ([3-Galf) containing-GIPCs found
in Paraccocidioides brasiliensis and A. fumigatus [32, 34]. On the other hand, the
GIPCs found in A. nidulans appear less strongly recognized by sera from a
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patient with aspergillosis [34], These features could be exploited for the
development of diagnostics based on recognition of GIPCs by serum antibodies
in patients with mycoses. The structural characterization of fungal GIPCs will aid
in the development of diagnostics, as well as in functional studies where the role
of these compounds in life cycle, infectivity and interactions with the host immune
response may depend on structural features of the glycosylinositol moiety.
Importance of Fungi
Fungi are major pathogens of agricultural plants and important endemic
and opportunistic pathogens of humans [41]. The susceptibility to infection by
opportunistic and other fungal pathogens has risen due to an increase in the
population of immunocompromised persons, including HIV infected, cancer,
organ and tissue transplant, and other critically ill patients [42-44]. The common
opportunistic fungal pathogens include Candida albicans, Aspergillus fumigatus
and Cryptococcus neoformans [43]. The increased patient population at risk, as
well as increased resistance to antifungal drugs, has led to a need for
development of alternative effective chemotherapeutic agents [41, 44].
Differences in the pathways of sphingolipid metabolism in phylogenetically
different organisms could be exploited for the development of new anti-infectiousdisease drugs. In fungi, inhibitors of the enzyme IPC synthase have been studied
as potential targets for development of new antifungals, because this enzyme
has no mammalian correlate [45-50]. Since ideal antifungal agents would be
directed at biosynthetic pathways that are uniquely essential to the fungi, these
efforts can benefit from a better understanding of fungal life cycle and
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developmental biology at the molecular level. One of the goals of performing
structural characterization of GSLs is to aid functional studies. Since the polar
head groups of the GSLs are structurally diverse even in closely related fungal
species, the other goal is to exploit this diversity in the development of diagnostic
or immunodiagnostic agents in the case of antigenic GIPCs.
Structural characterization of GSLs
Structural characterization is an important component of elucidating the
role of glycoconjugates in development and pathology. Since GSLs have a wide
variety of structures and physico-chemical properties, traditional methods used
for their extraction and structural determination are not universal, as they
generally target a specific subset of GSLs, or GSLs of a particular organism, and
are not suited for high-throughput (HTP) analysis. In order to improve on the
current protocols, new methods applicable to a wide range of GSLs, irrespective
of their structural features and physico-chemical properties, compatible with a
variety of instrumental analysis, and adaptable for high-throughput applications
with minimal sample handling, should be developed. The complete structural
characterization of GSLs requires the analysis of both their ceramide forms and
their head groups. The main challenge in the structural characterization of
glycans as opposed to linear biopolymers like proteins and nucleic acids arises
from different anomeric configurations, multiple hydroxyl linkage sites,
possibilities for branching, isomerism, and hydroxyl group modifications such as
sulfation, phosphorylation and acetylation.
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Current fungal lipid extraction, fractionation and purification protocols
require multiple steps (sometimes repeatedly performed), using a variety of
mixed polarity solvents, in order to obtain lipid fractions that are separated into
neutral and anionic fractions by anionic exchange chromatography, then further
purified by preparative high performance liquid chromatography (prep-HPLC),
column chromatography or preparative high performance thin layer
chromatography (prep-HPTLC). In order to unambiguously determine glycan
structure, it is required to determine the identity of all monosaccharide residues;
their sequence, including branching topology, (if necessary), glycosyl linkage
sites; anomeric configuration; and the primary structure and linkage of all non
sugar modifying groups. This process requires the use of a wide array of
analytical techniques. Complete analysis typically requires nuclear magnetic
resonance spectroscopy (NMR) and/or mass spectrometry (MS) [40, 51]. In
addition, other techniques, such as the release of the glycans or glycosylinositols
(GIs) using enzymes and/or chemical degradation may be used. Finally,
complete chemical degradation and derivatization may be employed to yield
suitable derivatives to perform fatty acid, sphingoid, inositol and monosaccharide
component and linkage analysis by gas chromatography-mass spectrometry
(GC-MS).
MS is of fundamental relevance to GSL structural determination. Since
1990, MS instruments of unique analytical capabilities such as matrix-assisted
laser desorption/ ionization MS (MALDI-MS), electrospray ionization MS (ESI-MS
and ESI-MSn) and collision induced MS (CID-MS) have typically been used for
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analysis of underivatized GSLs in positive or negative ion mode. Cation-adducted
non-derivatized GSLs and permethylated or otherwise derivatized GSLs have
been analyzed in positive ion mode either as protonated or cation adducts [52].
One dimensional proton or carbon-13 NMR (1-D NMR (1H and

13

C) has been

used to give complementary structural information where sample is limited. In
situations where sample quantity does not present a limitation, two dimensional
NMR (2-D NMR) techniques are often used. These techniques all provide useful
information that is combined to determine structure. Chapter II of this
dissertation describes the use of conventional protocols for extraction, isolation,
purification and structural characterization of fungal GSLs.
A frequent problem confounding glycan structural analysis is the
prevalence of isomeric/isobaric structures sometimes in irresolvable mixtures.
Recent studies point to a promising future for the use of permethylation,
traditionally used in protocols for determining glycan sequence and linkage by
MS and GC-MS, to detect and distinguish various isobars based on the
abundance of the product ions formed in ion trap multistage MS (MSn) analysis
[53-55]. In Chapter III of this dissertation I examine the potential use of
permethylation and MSn for molecular dissection of permethylated
glycosylinositols (GIs). The MSn analysis of the GIs yields more useful
information on sequence and linkage in less time than traditional methodologies,
with a minimal number of derivatization steps.
Attempts to improve methods for GSL characterization have led us to use
a newly discovered, commercially available enzyme, sphingolipid ceramide-A/-
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deacylase (SCDase) from Pseudomonas spp., (Takara Bio, Shiga Japan) [56,
57], This enzyme provides a means to an alternative derivatization pathway that
can potentially be utilized for the development of improved methods for GSL
extraction and analysis. The activity of SCDase on mammalian GSLs has been
extensively validated and used for removal of the fatty acyl chain of the ceramide
moiety, while leaving the sphingoid base and glycan intact. One disadvantage of
the this reaction is that we lose some structural information as a result of the
removal of the fatty acid; however, this is not an issue when we are dealing with
GSLs whose ceramide compositions have previously been well established.
Furthermore, this method can eliminate complexities arising from the distribution
of the same glycan among ceramide variants differing in chain length and
functionalization. In Chapter IV I describe the activity of this enzyme toward
fungal GIPCs, and its use for GIPC derivatization via reaction of the resulting
lyso-GIPCs with amine reactive reagents. Derivatization of GSLs with
fluorocarbon affinity tags potentially provides a means of purifying the GSLs by
fluorous solid phase extraction (F-SPE) or on-line HPLC-based separations.
One of the proposed projects involved constructing GIPC arrays for binding
studies and HTP analysis of protein-GIPC interactions. Fluorous chemistry
potentially provides a means to purify and immobilize GSLs using a single tag,
and should be suitable for developing improved HTP strategies for analysis.
Chapter IV and V address the development of new strategies utilizing Ndeacylated GSLs, which are derivatized using fluorocarbon reagents or
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bifunctional linkers. Both were studied for potential use in development of GSLbased glycan microarrays.
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CHAPTER II

CHARACTERIZATION OF GLYCOSPHINGOLIPIDS FROM FUNGI

Characterization of Neutral and Acidic Glvcosphinqolipids from the LectinProducing Mushroom, Polvoorus sauamosus
Introduction
The polypore mushroom Polyporus squamosus is the source of a lectin
that exhibits a general affinity for terminal (3-galactosides, but appears to have an
extended carbohydrate-binding site with high affinity and strict specificity for the
non-reducing terminal trisaccharide sequence NeuAca2-»6Gal|31—>4Glc/GlcNAc
[58]. Negligible binding was observed with oligosaccharides bearing the isomeric
terminal trisaccharides NeuAca2—>3Gal(31—>4Glc/GlcNAc or Galf31—>3
(NeuAca2—>6 )GlcNAc The specificity of the lectin towards NeuAca2—►6Gal(31—>
terminated glycans suggests considerable potential for its use in glycobiological
studies, but its in vivo function is unknown. In considering the possibility that the
lectins function could involve interaction with an endogenous glycoconjugate, it
would clearly be helpful to identify candidate ligands among various classes of
carbohydrate-containing materials expressed by P. squamosus. Since evidence
has been accumulating that glycosphingolipids (GSLs) may serve as key ligands
for some endogenous lectins in animal species [59], possible similar roles for
fungal GSLs could be considered.
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Two sub-classes of GSLs appear to be widely expressed in the fungal
kingdom: (i) monohexosylceramides, such as glucosylceramide (GlcCer) and
galactosylceramide (GalCer); and (ii) glycosylinositol phosphorylceramides
(GIPCs), which comprise a structurally diverse class of anionic and zwitterionic
fungal (and plant) biosynthetic products [13, 29, 30, 32, 36-38, 40, 60-64],
capable of bearing non-reducing terminal Galp[31—►residues [29, 38].
Interestingly, the ceramides found in CMHs of most fungi are structurally distinct
from those found in GIPCs, suggesting that the corresponding lipid acceptor
substrates are with few exceptions [15] synthesized in divergent pathways
adapted for different physiological functional roles [10,11, 14, 18, 65,

6 6

]

(compare ceramide structural features in Schemes 2.1 and 2.6). Mushrooms and
other basidiomycetes that have so far been examined appear to express GlcCer,
and not GalCer, with typical cerebroside ceramide features widespread in the
fungal kingdom. In addition, GIPCs of most basidiomycetes have been found to
possess complex glycans which are highly diversified in structure, but based on a
characteristic core motif, Gal|31—>6Mana1—>2lns-P-Cer (where Ins = myo-inositol,
P = phosphodiester, Cer = ceramide; Scheme 2.1, Ba-2). This core has not been
found in yeasts such as Saccharomyces cerevisiae or Candida albicans, nor in
filamentous fungi (e.g., euascomycete species); so far the most widely distributed
GIPC core in euascomycetes has been found to be M ana1^3M ana1—>2lns-PCer (Scheme 2.1, Eu-2), along with less frequently observed alternate core
structures based on Maned—>6 lns-P-Cer and G lcN al—>2lns-P-Cer [13, 30, 33,
36, 63]. In this work the extraction and characterization of the major cerebroside
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and GIPC components of mature fruiting body of P. squamosus was done using
one- and two-dimensional nuclear magnetic resonance (NMR) spectroscopy,
electrospray ionization mass spectrometry (ESI-MS, -MS/CID-MS, and -pseudo[CID-MS]2) in a hybrid quadrupole/time-of-flight (ESI-Qq/oa-TOF-MS) instrument,
multistep fragmentation in an ion trap-mass spectrometry (ESI-IT-MSn)
instrument and gas chromatography/mass spectrometry (GC/MS).

IPDAG
AUR1

SUR1/CSG1
CSG2

Galp6Ma2IPC

Ma2IPC

B a-2

Ma3Ma2IPC

E u -2a

Scheme 2.1. Biosynthesis of fungal GIPCs starting with transfer of myo-inositol1-O-phosphate (IP) from diacylglycerol (DAG) moiety of phosphatidylinositol to
ceramide, catalyzed by AUR1 gene encoded IPC synthase. Common
intermediate Maned—>2lnsPCer (Ma2IPC) is next synthesized by action of
Mana2-T (encoded by SUR1/CSG1, CSG2, or both). In S. cerevisae, IPT1encoded protein transfers a second mole of myo-inositol-1 -O-phosphate from
phosphatidylinositol to Ma2IPC to make PIMa2IPC [24, 67]. In many filamentous
fungi, an as yet unknown Mana3-T (X) transfers a second a-Man residue to
Ma2IPC to make a common intermediate Ma3Ma2IPC (right arrow). In most
basidiomycetes, including mushrooms and Cryptococcus neoformans, an as yet
unknown Gal|36-T (Y) transfers a |3-Gal residue to Ma2IPC to make a common
intermediate Gal06Ma2IPC (left arrow).
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Materials and Experimental Methods

Fungal GIPC Fractions
Carpophores of P. squamosus (Huds.) Fr. were collected in late
summer 1998 from a decaying Ulmus stump in Ann Arbor, Michigan [58]. Freezedried samples of the fruiting body were used as the source of GSLs for this
study. The GIPCs were isolated prior to my involvement with the project as
previously described [40]. Supporting NMR spectroscopy data were acquired by
Steven B. Levery with experimental details and interpretation of spectra
described in Arigi et al [6 8 ].
Mass spectrometry
Mass spectrometry of GIPCs was performed in the positive ion mode on a
Micromass (Manchester, UK) hybrid ESI-Qq/oa-TOF-MS instrument, with GIPC
sample introduction via direct infusion in 100% MeOH (~100 ng/pL). A nano
spray capillary tip was employed, from which the flow rate was estimated to be
~200 nL/min. Mass spectrometry of GlcCer was also performed via positive ion
mode ESI, but on a linear ion trap (LTQ, ThermoFinnigan San Jose, CA). Lithium
iodide (10 mM in MeOH) was added to the analyte solution to form predominant
[M+Li]+ adducts of GlcCer and [M(Li)+Li]+ adducts of GIPC molecular species
(lithium adduction of GSLs reviewed, [52] the final Lil concentration was ~2-3 mM
in the former case [13] and ~ 5-6 mM in the latter [35, 40]. Conditions for
acquisition of GIPC [M(Li)+Li]+ adduct spectra on an ESI-Qq/oa-TOF-MS
instrument were essentially as described by Bennion et al [40]. Nominal,
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monoisotopic m/z values are used in the labeling and description of +ESI-MS
results. Interpretation of spectra derived from [M(Li)+Li]+ adducts of GIPC
molecular species was essentially as described previously [35, 40, 52].
Interpretation of ESI-QIT-MS [M+Li]+ profiles and -MSn spectra for GlcCer was
essentially as described previously for those acquired on triple-quadrupole [13],
Q-TOF [51], and MALDI-QIT-TOF [7] instruments.
Release and Permethylation of Glycosylinositols
Release of glycosylinositols from GIPCs by ammonolysis was performed
using 10N NH4 OH at 150°C for 24hr as previously described [32].The released
glycosylinositols were permethylated using the method of Ciucanu and Kerek
[69] with the modification of Ciucanu and Costello [70]. Briefly NaOH was added
to the sample dissolved in DMSO and the mixture vortexed to form a white
suspension, lodomethane was added and the solution further vortexed for 1 hr.
The reaction was terminated using HPLC grade water and the permethylated
glycosylinositols were extracted three times using dichloromethane. The extracts
were combined and dried down under N2.
Glvcosvl Linkage Analysis by GC/MS
The permethylated glycosylinositols (see above) were hydrolyzed and
derivatized for analysis as partially methylated alditol acetates (PMAAs) using the
protocols described by Levery and Hakomori [71]. The PMAAs were analyzed on
an Rtx-5MS bonded phase fused silica capillary column (30 m *0.25 mm; 0.25
pm phase thickness; Restek Corporation, Bellefonte, PA) in the splitless mode
using a Trace GC ultra gas chromatograph interfaced to a Polaris Q ion trap
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mass spectrometer, GC/MS (Finnigan MAT, San Jose, CA) operated in El mode.
The GC temperature was programmed essentially as described [32], The
derivatives were identified by retention times and characteristic El mass spectra
compared with those of authentic standards [72, 73].
Monosaccharide. Inositol. Fatty Acid, and Sphingoid Component Analysis bv
GC/MS
Analysis of the composition of the GIPCs by GC/MS was performed
following acid catalyzed methanolysis, re-A/-acetylation and preparation of per-Otrimethylsilyl (TMS) derivatives. All derivatives were prepared and analyzed
according to protocols described previously as follows [32, 74-76], Methanolysis
was carried out with 1N HCI in anhydrous methanol at 80°C, for 16h. At the end
of this period, the sealed tubes were cooled to room temperature, followed by
extraction twice with 100pL of n-hexane to extract fatty acid methyl esters
(FAMEs). The washes were combined in 13x100 teflon-lined-screw-cap vials for
separate GC-MS analysis. The methanolic HCI was dried under N2 stream at 3540°C. Re-/V-acetylation of the dried residues was then performed to ensure that
hexosamines, if present, as well as sphingoid bases, would be detected as their
acetamido derivatives. For this purpose the methanolyzed sample was dissolved
in 50pL pyridine and 50pL acetic anhydride in 500pL methanol. The sample was
vortexed and left standing for 2 0 min at room temperature, following which
evaporation to dryness under N2 at 35-40°C was performed. Per-Otrimethylsilylation was done using Tri-sil reagent (Pierce Biotechnology, Inc.,
Rockford, IL). Tri-sil (200pL) was added to the residue, and the test tubes were
flushed with N2. The sealed test tube was heated for 80°C for 20-30min, after
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which the sample was cooled to room temperature and excess reagent
evaporated just to dryness under a N2 stream. The white residue was extracted
twice with n-hexane (100pL) and the washes combined in a small teflon-linedscrew-cap vial for GC-MS analysis. Monosaccharides were separated and
detected as their per-O-trimethylsilyl methyl glycosides. Ceramide-derived
sphingoid bases and 2 -hydroxyl fatty acids were also separated and detected as
their A/-acetyl-per-0-trimethylsilyl and 2-O-trimethylsilyl methyl ester derivatives,
respectively. The derivatives were analyzed by GC-MS according to protocols
described previously [32]. The identity of the derivatives was based on their
characteristic retention times and their El mass spectra, compared with data from
the literature and, where necessary, authentic standards. The instrument used
was a GCQ (Finnigan MAT, San Jose, CA) operated in electron ionization (El)
mode. Myo-inositol was detected in the monosaccharide analysis as its per-Otrimethylsilyl derivative, although optimal conditions for its release [62] were not
employed.
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Scheme 2.2. Characteristic fragmentations of glycosylated IPCs, represented by
MIPC (Ps-1) under conditions of positive ion ESI-Qq/oa-TOF-MS. Panel A,
nomenclature of Adams and Ann [77] for fragmentation of ceramide moiety, and
of Costello and Vath [78] and Singh et al. [79] for glycosylinositol phosphoryl
group; Panel B, sphingoid d3b ion, proposed by Hsu and Turk [80]; Panel C,
hydrated analog of the d3b ion, poposed in this study as a product of t18:0 or
t20:0 phytosphingosine-containing ceramides; Panel D, sphingoid Cib ion
proposed by Hsu and Turk [80]; Panel E, hydrated analog of c1b ion, proposed in
this study as a product of t18:0 or t2 0 : 0 phytosphingosine-containing ceramides.
The adduct designation “+Li” and the charge form have been omitted from the
labels for clarity.

Results

Monosaccharide, inositol, fatty acid, and sphingoid component analysis of P.
squamosus GIPCs
Following methanolysis of the three putative GIPC fractions of P.
squamosus, i.e., Ps-1, Ps-2 and Ps-5, GC/MS analysis of monosaccharides as
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their TMS methyl glycosides showed Ps-1 to consist of mannose as a dominant
sugar component, consistent with a MIPC. Ps-2 yielded mannose and galactose
in -2:1 ratio, consistent with a mixture of MIPC and an MIPC derivative with a
galactose residue added (GalMIPC) in -1:2 ratio. Ps-5 yielded fucose, galactose
and mannose in -1:2:2 . 6 ratio, suggesting a GIPC with 1 fucose, 2 galactose and
2-3 mannose residues, consistent with the substantially decreased Rf value for
this fraction. Glucose was detected in all the GIPC fractions; however, based on
subsequent MS and NMR analysis, its source was considered to be a non-GIPC
impurity. Myo-inositol was also detected in all the GIPC fractions. The GC/MS
analysis of the fatty acid methyl esters (FAMEs) and A/-acetyl-sphingoid-0-TMS
derivatives exhibited abundant peaks for 2 -hydroxy fatty acids and
phytosphingosines. Ceramides of Ps-1, Ps-2 and Ps-5 were found to be
composed primarily of (t18:0) 4-hydroxy-sphinganine A/-acylated with h22:0,
h23:0 and h24:0 in all the fractions (Figures B.1-B.4). The GC retention times
and El mass spectra corresponding to each of the peaks were identical to those
of authentic standards. The El spectrum of the A/-acetyl-1,3,4-tri-O-trimethyl(t18:0)-4-hydroxy derivative had peaks corresponding to [M -15]+, [M-15-90]+,
[M -59-90]+, [M -174]+ and [M -174-90]+ ions observed at m/z 560, 470, 426,
401, and 311 respectively [32, 81]. The long chain monohydroxy fatty acids had
El spectra with peaks corresponding to [M]+, [M -15]+, and [M -59]+ ions similar to
previously reported data [76]. Also detected in Ps-1 was a trace of dihydroxy
fatty acid (dh24:0). The presence of dh24:0 was confirmed using FAME
derivatives of the threo and erythro forms of 2,3-dihydroxy palmitic acid (dh16:0)
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as standards. Although the precise stereochemistry based on retention times
was not confirmed, the El spectrum of dh24:0 qualitatively resembled that of
dh16:0, but with the addition of 112 amu to the major ions observed (Figures
B.6-B.11). The spectrum was distinctly different from that of the monohydroxy
fatty acids, with ions corresponding to [M—15]+, [M -59]+, [M -15-90]+, and
[M -161]+ observed at m/z 543, 499, 453 and 397 respectively (compare results
of Heise et al [37, 82] and Mayberry [82]).
Glvcosvl Linkage Analysis by GC/MS
The glycosyl linkage structures of Ps-1, Ps-2 and Ps-5 were determined
by GC/MS of partially methylated alditol acetate derivatives (PMAAs) after
permethylation of the ammonia released glycosylinositols, followed by
depolymerization, reduction and peracetylation.
The structure of Ps-1 was confirmed by the detection of a derivative for a
terminal mannose (t-Manp) residue (1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0methyl-mannitol), consistent with an MIPC (Figure C.1). The linkage analysis of
Ps-2 yielded derivatives for both terminal galactose and mannose (t-Galp and tManp) residues (1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl-galactitol and
1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl-mannitol, respectively), as well
as a derivative fora

6

-linked Manp residue (1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tri-

O-methylmannitol) (Figures C.2-C.3). This is consistent with a mixture of MIPC
and Gal—>6 MIPC. The linkage analysis of Ps-5 was characterized by the
detection of a 6 -linked Manp residue, a t-Manp, a 2-linked Galp (1,2,5-tri-Oacetyl-1-deuterio-3,4,6-tri-0-methyl-galactitol), and a 6 -linked Galp (1,5,6-tri-O-
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acetyl-1-deuterio-2,3,4,-tri-O-methyl-galactitol) (Figures C.5-C.6). Interestingly, a
3-linked fucose derivative (1,3,5-tri-0-acetyl-1-deuterio-6-deoxy-2,4-di-0-methylgalactitol) was also detected (Figures C.4B). The absence of any branching
residue derivatives suggested that Ps-5 has an unbranched structure, wherein
the 6 -linked Manp is assumed to originate from an MIPC core, while the t-Manp
originates from a mannose residue at the non-reducing terminal. The presence of
an internal sequence comprised of two galactoses and a fucose residue was also
indicated, consistent with the monosaccharide analysis.
+ESI-MS and -MS/ClD-MS Analysis of P. squamosus GIPCs
Ps-1.

Major molecular adduct species [M(Li)+Li]+ in the ESI-Q/oa-TOF-MS

profile of Ps-1 (Figure 2.1) were observed at m/z 1100, 1086, and 1072,
consistent with monohexosyl-IPCs having ceramides containing t18:0 4hydroxysphinganines with h24:0, h23:0 and h22:0 fatty A/-acylation, respectively.
The +ESI-MS/CID spectra acquired from the dilithiated molecular adduct at m/z
1072 and 1100, respectively, were similar to previous +ESI-MS/CID spectra
obtained from a mushroom MIPC using a triple quadrupole instrument [40],
exhibiting pairs of non-phosphorylated fragments representing the non-reducing
end of the glycosylinositol observed at m/z 169 and 187 [Hex+Li]+ ([Bi+Li]+ and
[Ci+Li]+, respectively), and at m/z 331 and 349 [Hex«lns+Li]+ ([B2 +Li]+ and
[C2 +I_i]+, respectively). A pair of glycosylinositol phosphate fragments
[Hex«lns«P+Li2]+ were observed at m/z 417 and 435 ([B2 P 0 3 (Li)+Li]+ and
[C2 P 0 3 (Li)+Li]+, respectively). Ceramide related product ions from the molecular
ion m/z 1072 included m/z 644 ([Z0 +Li]+), 662 ([Y0 +Li]+), 730 ([Z0 PO 3 (Li)+Li]+),
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and 748 ([y 0 PO 3 (Li)+Li]+), consistent with a t18:0/h22:0 ceramide component. A
uniform increment of m/z 28 was observed for the ceramide-related products of
the m/z 1100 molecular ion, i.e. 672 ([Z0 +Li]+), 690 ([Y0 +Li]+), 758 ([Z0 PO 3
(Li)+Li]+), and 776 ([Y0 PO 3 (Li)+Li]+) consistent with a t18:0/h24:0 ceramide
component. These cleavages are summarized in Schemes 2.2 and 2.3, Tables
1 and 2.
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Figure 2.1. Positive ion ESI-Qq/oa-TOF-MS of Fr 27-30 (Ps-1). A: Molecular ion
profile as Li adducts.B: MS/CID-MS of [M(Li)+Li]+ at m/z 1072 C: MS/CID-MS of
[M(Li)+Li]+ at m/z 1100.
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Scheme 2.3. Fragmentation of GIPC Ps-1 in positive ion ESI-Qq/oa-TOF-MS;
ion designations according to Costello and Vath [78], and Singh et al [79]. The
adduct designation “+Li” and the charge form have been omitted from the labels
for clarity.
Ps-2. Two sets of molecular adducts ions were observed in the [M(Li)+Li]+
profile of Ps-2 obtained by ESI-Q/oa-TOF-MS. In addition to a group of ions at
m/z 1100, 1086, and 1072, consistent with the same set of monohexosyl-IPC
species observed in Ps-1 (data not shown), an abundant second group of
[M(Li)+Li]+ species could be observed at m/z 1262, 1248, and 1234 (Figure 2.2,
Panel A). These values correspond to addition of a uniform m/z 162 increment to
the first group of ions, consistent with addition of a second hexose residue to Ps1. The +ESI-MS/CID spectra from the dilithiated molecular adduct at m/z 1262,
reproduced in Figure 2.2, Panel B, exhibit an abundant pair of glycosylinositol
phosphate fragments at m/z 579 and 597, corresponding to [B3 P 0 3 (Li)+Li]+ and
[C3 P 0 3 (Li)+Li]+ respectively.
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Figure 2.2. Positive ion ESI-Qq/oa-TOF-MS of Fr 31 (Ps-2). A: Molecular ion
profile as Li adducts.B: MS/CID-MS of [M(Li)+Li]+ at m/z 1262 (low m/z region).
Pairs of ions at m/z 417 and 435, and at m/z 255 and 273, are consistent
with additional glycosidic cleavages within the glycosylinositolphosphate ion,
corresponding to [Y2 /B 3 P0 3 (Li)+Li]+ and [Y2 /C 3 PO 3 (Li)+Li]+, and to
[Yi/B 3 P 0 3 (Li)+Li]+ and [Yi/C 3 P 0 3 (Li)+Li]+, respectively (see Scheme 2.4).
Non-phosphorylated glycosylinositol fragments include m/z 493 and 511,
corresponding to [B3 +Li]+ and [C3 +Li]+ ions, respectively. Other fragments include
m/z 331 ([Y2 /B 2 +Li]+) and 349 ([Y2 /C 2 +Li]+), and ceramide related ions 672
([Z 0 +Li]+), 690 ([Y0 +Li]+), 758 ([Z0 PO 3 (Li)+Li]+), and 776 ([Y0 PO 3 (Li)+Li]+), again
consistent with a t18:0/h24:0 ceramide component. The data are summarized in

Tables 1 and 2, Schemes 2.2 and 2.4. Together with the glycosyl composition
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and linkage analysis, these data are consistent with a Gal—>6 MIPC structure for
Ps-2, with the fraction also containing significant amount of MIPC (Ps-1), and
with both having similar ceramide component profiles. The complete linkage
structure and residue configurations in Ps-2 were ultimately confirmed to be
Gal(31 —>6Mana2IPC by NMR spectroscopy [6 8 ].
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Scheme 2.4. Fragmentation of GIPC Ps-2 in positive ion ESI-Qq/oa-TOF-MS;
ion designations according to Costello and Vath [78], and Singh et al [79]. The
adduct designation “+Li” and the charge form have been omitted from the labels
for clarity.
Ps-5. The major molecular adduct species [M(Li)+Li]+ in the ESI-Q/oaTOF-MS profile of Ps-5 (Figure 2.3, Panel A) are observed at m/z 1732, 1718,
and 1704, corresponding to the set of Ps-2 molecular adduct ions uniformly
incremented by two hexose and one deoxyhexose residues

(2

x m/z 162 + m/z

146 = m/z 570). Reproduced in Figure 2.3, Panels B and C, are +ESI-MS/CID
spectra of the dilithiated molecular adduct at m/z 1704, acquired at low collision
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energy and high collision energy, respectively. In these spectra, the fragment at
m/z 1067 is consistent with an intact glycosylinositol phosphate moiety having
the expected composition [deoxyHex*Hex4*lns*P+Li2]+ (corresponding to
[C6P0 3 (Li)+Li]+). Glycosidic cleavages within the glycosylinositol phosphate
fragment are represented by loss of a hexose residue (m/z 162 decrement),
yielding an ion m/z 905 ([Y5 /C 6 P 0 3 (Li)+Li]+); loss of a hexose and a deoxyhexose
residue (m/z 162 + m/z 146 = m/z 308 decrement), yielding a highly abundant ion
m/z 759 ([Y4 /C 6 P 0 3 (Li)+Li]+); and further sequential losses of residues along the
chain, yielding ions at m/z 597 ([Y3 /C 6 P 0 3 (Li)+Li]+), m/z 435 ([Y2 /C 6 P 0 3 (Li)+Li]+),
and m/z 273 ([Yi/C 6 P 0 3 (Li)+Li]+) (see Scheme 2.5). The corresponding
[B6 P 0 3 (Li)+Li]+ fragment m/z 1049 undergoes analogous sequence-specific
losses of hexose or deoxyhexose residues to yield ions at m/z 741
([Y4 /B 6 P 0 3 (Li)+Li]+), m/z 579 ([Y 3 /B 6 P 0 3 (Li)+Li]+), and m/z 255
[Yi/B 6 P 0 3 (Li)+Li]+). Other significant ions include unphosphorylated fragments
observed at m/z 1542 ([Y 5 +Li]+), m/z 1396 ([Y4 +Li]+), m/z 1234 ([Y3 +Li]+), m/z 963
([B6 +Li]+) and m/z 981 ([C 6 +Li]+). Summarized in Tables 1 and 2, and Schemes
2.2 and 2.5, these data are consistent with a pentaglycosyl-IPC structure for PS5, which must have the linear sequence Hex-deoxyHex-O-Hex-O-Hex-O-Hex-OInsPCer to be consistent with the results of the glycosyl linkage analysis.
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Figure 2.3. Positive ion ESI-Qq/oa-TOF-MS of Fr 33-34 (Ps-5). A: Molecular ion
profile as Li adducts. B: MS/CID-MS of [M(Li)+Li]+ at m/z 1704, low collision
energy (57 eV) and C: MS/CID-MS of [M(Li)+Li]+ at m/z 1704, high collision
energy (78 eV).
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Scheme 2.5. Fragmentation of GIPC Ps-5 in positive ion ESI-Qq/oa-TOF-MS;
ion designationsaccording to Costello and Vath [78], and Singh et al [79], The
adduct designation “+Li” and the charge form have been omitted from the labels
for clarity.
The terminal hexose must be a mannose residue (T-Man) based on
linkage analysis. The abundant fragments at m/z 1396, 759, and 741,
corresponding to combined losses of a hexose and a deoxyhexose residue (m/z
308 decrements from the molecular adduct ion and the two glycosylinositol
phosphate ions) imply that the —>3Fuc residue identified in the linkage analysis
represents the penultimate residue to which the terminal Man is attached. Given
the likely assumption that the other Man residue identified in the linkage analysis
(—>6 Man) is directly linked to IPC to form a ManlPC core, the next two internal
hexoses in the sequence must be the —>2Gal and —>6 Gal residues observed in
the linkage analysis, one of which must be linked 1— > 6 to the ManlPC core. The
order of the -^2Gal and —>6 Gal residues is not further specified by any of the
data so far. Overall, the data are consistent with the partial sequence
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Man—>3Fuc—>2/6Gal—>6/2Gal—>6ManlPC. The complete linkage sequence and
residue anomeric configurations in Ps-5 were ultimately determined by ESI-ITMSnof the permethylated glycosylinositol and 1- and 2-D NMR methods to be
Maned—►SFuccrt—>2Gala1—>6Gal(31—>6ManalPC [68].

TABLES DESCRIBING FRAGMENTATION
Table 2.1. Molecular adduct ions [M(Li)+Li] observed in ESI-Q/-TOF-MS profile (A), and significant

ceramide-containing product ions (m/z) formed in low energy Q-TOF ESI-MS/CID-TOF-MS spectra of
mono-, di-, and pentaglycosylinositol phosphorylceramides from fruiting body of P. squamosus (Ps).
Fragment designations as in Costello and Vath[78], as expanded for GIPCs in Singh et al [79], with
modifications of Adams and Ann [77] for ceramide-derived ions; illustrated in Schemes 2.3-2.5.
Fraction:
Fatty acid
Sphingoid:
[M (L i)+ L i]+:

[M(Li) - Hex+Li]+
[M(Li) - Hex - dHex + L if
[M(Li) - 2Hex - dHex + Li]+
[M(Li) - 3Hex - dHex + Li]+
[Y0PO3(Li)+Li]+
[Z0PO3(Li)+Li]+
[Z0PO3(Li)+Li-H2O]+
[Y0+Li]+
[Z0+Li]+
[O/Z0PO3(Li)+Li]+

Ps-la

Ps-lb

Ps-2

Ps-5

h22:0
tl 8:0
1072

h24:0
tl8:0
1100

h24:0
tl 8:0
1262

h22:0
tl8:0
1704

910

938

1100

—

1542
1396
1234
1072L
776
748
758
730
740La
690
662
672La
392L
—

. . . .

—

748
730
712L
662
644Va
392

776
758
712L
690
672
392

aL = low-abundance ion
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Table 2.2. Glycosylinositol- and phosphorylglycosylinositol-related product ions formed in low energy
ESI-MS/CID-TOF-MS spectra of mono-, di-, and pentaglycosylinositol phosphorylceramides from fruiting
body of P. squamosus (Ps). Base peak distinguished by bold font. Fragment designations as in Costello
and Vath [78], as expanded for GIPCs in Singh et al [79], illustrated in Schemes 3-5.
m/z

Ps-1

Ps-2

Ps-5

1085a
1067
1049
981
963
905

[C6P 0 3 + H20 (Li)+Li]+
[C6P 0 3(Li)+Li]+
[B6P 0 3(Li)+Li]+
[C6+Li]+
[B6+ L if
[Y5/C6P 0 3(Li)+Li]+

887

[Y5/B6P 0 3(Li)+Li]+

819
801
11T
759
741

[Y5/C6+Li]+ or [C5+Lif
[Y5/B6+Li]+ or [B5+Li]+
[Y4/C6P 0 3 + H20 (Li)+Li]+
[Y4/C6P 0 3(Li)+Li]+
[Y4/B6P 0 3(Li)+Li]+

673
655

[Y4/C6+Li]+
[Y4/B6+Li]+

597
579
511
493
453a
435a
417

[C2P 0 3+ H 20(Li)+Li]+
[C2P 0 3(Li)+Li]+
[B2P 0 3(Li)+Li]+

349
331
29 l a
273

[C2+Li]+
[B2+Li]+
[Y1/C2P 0 3+ H20 (Li)+Li]+

255

[Y,/B2P 0 3(Li)+Li]

237

[Z1/B2P 0 3(Li)+Li]+

187

[C,+Li]+
[B|+Li]'
[LiH2P 04+Li]+

169
111

[Y!/C2P 0 3(Li)+Li]

[C3P 0 3(Li)+Li]+
[B3P 0 3(Li)+Li]+
[C3+Li]+
[B3+Li]+

[Y3/C6P 0 3(Li)+Li]+
[Y3/B6P 0 3(Li)+Li]+
[Y3/C6+Li]+
[Y3/B6+Li]+ or [Z3/C6+Li]+

[Y2/C2P 0 3+ H20 (Li)+Li]+
[Y2/C3P 0 3(Li)+Li]+
[Y2/B3P 0 3(Li)+Li]+
[Y2/C3+Li]+ or [C2+Li]+
[Y2/B3+Li]+ or [B2+Li]+
[Y]/C3P 0 3+ H20 (Li)+Li]+

[Y2/C6P 0 3(Li)+Li]+
[Y2/B6P 0 3(Li)+Li]+
[Y2/C6+Li]+
[Y2/B6+Li]+

[Y,/C3P 0 3(Li)+Li]+
[Y,/B3P 0 3(Li)+Li]+

[Y,/C6P 0 3(Li)+Li]+

[Z1/B3P 0 3(Li)+Li]+
[Yj/C3+Li]+ or [Ci+Li]+

[Z,/B6P 0 3(Li)+Li]+

[Y!/B3+Li]+ or [Bi+Li]+
[LiH2P 0 4+Li]+

[Y1/B6P 0 3(Li)+Li]+
[Ci+Li]+
[B,+Li]+
[LiH2P 0 4+Li]+

aApparent H20 adducts do not appear consistently, and are considered to be artifacts.
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+ESI-MSn Analysis of P. squamosus Monohexosvl Ceramide
The major molecular ion species [M+Li]+ in the ESI-MS1 profile of the CMH
fraction (Figure 6, panel A, Inset) observed at m/z 734 is consistent with a
lipoform having a h16:0/d19:2 fatty acyl/sphingoid combination. The MS2 spectra
acquired from this adduct reproduced in Figure 2.4, Panel A, is analogous to
previously reported findings using low energy tandem [13, 51] and ion trap [7]
instruments, with characteristic ions at m/z 572 and 480 representing the loss of
a hexose residue (Yo fragment) and the h16:0 fatty acid residue (O fragment)
respectively (see Scheme 2.6). The h16:0 fatty-N-acyl group is included in the
characteristic ion at m/z 304 (T = Z0/G fragment), although this fragment appears
at much greater abundance in low energy tandem MS/CID-MS spectra [13, 51]
than in ion trap MSn spectra [7]. Further dissection of these primary precursors
via MS3 confirmed their presumptive origins and structural significance. Key MS3
products of m/z 572 (Figure 2.4, Panel B) included the characteristic d19:2
sphingoid (N = Yo/G) ion m/z 318, and the h16:0 fatty-N-acyl W ion m/z 233. Key
MS3 products of m/z 480 (Figure 2.4, Panel C) also included the characteristic
d19:2 sphingoid N ion m/z 318, as well as hexose ions m/z 169 (B-i) and 187
(Ci), and a pair of fragments from losses of NH3 (m/z 463) and H20 {m/z 462)
(the O fragment and the latter two products correspond to ions designated g-i, g2,
and g3, respectively, by Hsu and Turk [80],
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Figure 2.4. Positive ion ESI-MSn analysis of purified GlcCerfrom P. squamosus.
A: MS1 lithium adduct ion profile showing predominant adduct at m/z 734 (inset)
and MS2 product ion spectrum of selected precursor at m/z 734. B: MS3 product
ion spectrum of selected Y0 fragment precursor at m/z 572 (m/z 734—>572—►). C:
MS3 product ion spectrum of selected O fragment precursor at m/z 480 (m/z
734—>480—»).
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H --0
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OH
HO
OH

H --0

CH

Scheme 2.6. Structure of prototypical fungal glucosylceramide, (4E,8E)-A/-2”hydroxyhexadecanoyl-1-(3-D-glucopyranosyl-9-methyl-4,8-sphingadienine, along
with fragmentation nomenclature of Costello and Vath [78] as modified by Adams
and Ann [77].

Discussion

In this work, both types of fungal GSLs, monohexosylceramide and
GIPCs, were extracted from the fruiting body of P. squamosus and characterized.
The P. squamosus monohexosylceramide was found to be GlcCer exclusively,
as previously observed for basidiomycete species, with a typical basidiomycete
structure characterized by the absence of fatty-A/-acyl A3-unsaturation, the
predominant ceramide having an h16:0/d19:2 fatty-/V-acyl/sphingoid composition
(for extended reviews of fungal GlcCer structure, biosynthesis, and function, see
[15, 66]. The structures of three major GIPCs, Ps-1, Ps-2, and Ps-5, were
elucidated, with the latter found to have a previously unreported
pentaglycosylinositol headgroup structure. The ceramide moieties of the GIPCs
had typical phytoceramide structures found in other fungi. [15, 66]. The
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predominant GIPC sphingoid was found to be t18:0 4-hydroxysphinganine
(phytosphingosine), in combination with h22:0 and h24:0 as the predominant
long-chain fatty-/V-acyl moieties. In Ps-1, dihydroxy fatty-/V-acylation (dh24:0)
was also detected as a minor component. Ps-1 represents a common Mana2IPC
core structure found in many fungi [13, 29, 32, 37, 40, 83]; Ps-2 represents
modification of Mana2IPC by addition of a Gal(36 residue to form
Gaip6Mana2IPC (Ba-2; see Scheme 2.1), a core structure typical of almost all
basidiomycete species so far characterized [37, 39, 83], while not being
observed in other types of fungi, such as saccharomycetales (e.g.,

Saccharomyces and Candida spp.) or euascomycetes (filamentous or thermally
dimorphic species, e.g., Aspergillus spp., Histoplasma capsulatum,

Paracoccidioides brasiliensis, Sporothrix schenckii). Ps-5 was found to have the
structure Mana3Fuca2Gala6Gal(36Mana2IPC, consistent with sequential
elongation of Ps-2/Ba-2 with three additional monosaccharide residues. All three
of these residues, Gala6, Fuca2, and Mana3, have been observed previously in
mushroom GIPCs, but so far not in a strictly linear sequence as found for Ps-5.
Understanding fungal GSL functions, particularly in terms of their
interactions with endogenous carbohydrate- or lipid-binding proteins at the
molecular level, is at a very early stage. The lectin from P. squamosus strongly
recognizes NeuAca2-^6Gaipi-^ terminated glycans; the lectin also recognizes,
albeit more weakly, non-sialylated terminal Gal residues [58, 84], Ps-2/Ba-2,
which makes up a significant fraction of P. squamosus GIPCs, does possess a
terminal 3-Gal residue, suggesting it could potentially interact with P.squamosus
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or other fungal lectins. Future work could involve the study of possible
interactions of fungal GIPCs with lectins from P. squamosus and other
mushrooms. Such further investigations could provide insights on the role of
GIPCs in the fungal life cycle and developmental biology.

Characterization of Glycosphingolipids from the Mushroom
Coprinus cinereus

Introduction
Lectins are proteins (sometimes, glycoproteins) that bind specifically and
reversibly to carbohydrates. They are found in a variety of organisms including
plants, animals and fungi. The mushroom Coprinopsis cinerea (alternatively

Coprinus cinereus) also produces lectins (galectins), which bind galactosecontaining glyconjugates. Galectins are a ubiquitously distributed family of
carbohydrate-binding proteins that were initially defined, on the basis of structural
analysis and binding-specificity studies, to have a binding affinity for (3 galactosides, and in addition display conserved sequence elements in the
carbohydrate-binding site [85]. The galectin CGL2 isolated from the C.cinereus
fruiting body has an affinity for (3-galactosides with and extended binding affinity
for substituted (3-galactosides resembling mammalian blood group A
tetrasachharide GalNAca1-3[Fuca1-2]Gal(31-4Glc and B type determinants in the
extended binding site [86]. The differential expression and high regulation of

Coprinus galectins during different stages of fruiting body development suggests
that they play important functional roles during development [87]. Since recent
work has suggested that one or more GIPCs of C. cinereus may be potential
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ligands for these lectins during early development [86], this study was aimed at
identifying likely endogenous ligands for C. cinereus lectins. In this work the
structural characterization of GIPCs from the fruiting body and mycelia of C.
cinereus was performed using 1-D 1H-NMR and ESI-MS.

Experimental Materials and Methods
Fungal Isolate
Freeze dried samples of the fruiting body and mycelia of the mushroom C.
cinereus obtained from Markus Kunzler (Swiss Federal Institute of Technology
Zurich, Switzerland) were used as the source of GSLs for this study. They were
grown and harvested as described [87].
High Performance Thin Laver Chromatography
Analytical HPTLC was performed on silica gel 60 plates (E. Merck,
Darmstadt, Germany) using chloroform/methanol/water (50:47:14 v/v/v,
containing 0.038% w/v CaCI2; solvent C) as mobile phase for acidic lipids, and
chloroform/methanol/water (60:40:9 v/v/v, containing 0.025% w/v CaCI2; solvent
D) for neutral lipids. Acidic lipid samples were solubilized in
isopropanol/hexane/water; solvent A (55:25:20, v/v/v, upper phase discarded)
and applied by streaking from 5 pL Micro-caps (Drummond, Broomall, PA).
Neutral lipid samples were solubilized in chloroform/methanol; solvent B (1:1, v/v)
and applied similarly. Detection was made by Bial’s orcinol reagent (orcinol
0.55% [w/v] and H2SC>4 5.5% [v/v] in ethanol/water 9:1 [v/v]; the plate is sprayed
and heated briefly to ~200-250°C).
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Extraction and Purification of Glycosphinqolipids
Extraction, fractionation into neutral and acidic lipids on DEAE-Sephadex
ion exchange chromatography, and purification of acidic GIPCs from the DEAESephadex-retained fraction by preparative-scale HPLC, were carried out as
described previously [40]. The identity and purity of each acidic fraction from
HPLC was assessed by analytical HPTLC using solvent C as above, and those
containing putative GIPCs were further assessed by 1-D 1H-NMR spectroscopy
and MS techniques described below. (A summary of the extraction, fractionation
and purification steps is shown in Scheme 2.7 below).
Total lipid extraction using
mixed polarity solvents:
isopropanol:hexane:water
(55:25:20v/v/v),
chloroform:methanol (1:1v/v)

Fractionation DEAE-sephadex anion
exchange chromatography: Neutral
and Acidic fractions

0.5M
NaAc in
MeOH

C:M:W
30:60:8v/v/v

Partition in
butanol/water

1f

Neutral

Acidic fractions

i

Butanol
soluble
fraction

Dialyze against water

1

Base treatment with 25%
methylamine in
methanol/water/n-butanol 4:3:1
v/v/v at 55°C to destroy
diacylglyceroi lipids

I

Preparative-scale HPLC and or
prep-TLC

Scheme 2.7. Fungal lipid extraction, fractionation and purification.

44

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1-D 1H Nuclear Magnetic Resonance Spectroscopy
Samples of underivatized GIPC (~ 0.5-1.0 mg) were deuterium
exchanged by repeated lyophilization in D20 . The samples were dissolved in 0.6
ml_ DMSO-d6/2% D20 [88] for NMR analysis as described [30, 32, 40, 64]. 1-D
1H-NMR experiments were performed at 35°C on Varian Unity Inova 500 MHz
(Department of Chemistry, University of New Hampshire), spectrometer, using
standard acquisition software available in the Varian VNMR software package.
Electrosprav-lonization-MS Analysis
ESI-MS was performed on a Thermo-Finnigan (San Jose, CA) LCQ.
Samples were dissolved in methanol, and introduced by direct infusion at a flow
rate of 1 .OpL/min (spray voltage = 2.0 kV, capillary temperature = 200°C,
capillary voltage = 46.00 V, tube lens offset = 50.00 V).

Results and Discussion

HPTLC analysis of the neutral fractions showed each contained one
component with an Rf that corresponds to glucosylceramide (Figure 2.5). Since
this was not of particular interest for this study, no further analysis of this
component was undertaken. In the crude acidic GSL fractions from the fruiting
body, one major component was observed with Rf value identical to that of the
MIPC obtained from P. squamosus (Ps-1) (Figure 2.6). On subjection to HPLC
purification three bands of slightly different Rf, designated fractions 29, 30 and
31, were obtained (see Figure D.1).
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Figure 2.5. HPTLC (orcinol stain) of neutral lipids from C.cinereus. Mobile phase
chloroform-methanol-water (60:30:5 v/v/v). Lane S, standard containing GlcCer.

MIPC
GMIPC
Pentaglycosyl
Complex

S

1

2

3

S

Figure 2.6. HPTLC (orcinol stain) of GIPCs from C.cinereus. Mobile phase
chloroform-methanol-water (50:47:14 v/v/v) containing 0.038% w/v CaCk. Lane
S, GIPC standard containing Mana2IPC (MIPC), Gal|36Mana2IPC (GMIPC), and
Mana3Fuca2Gala6Gal(36Mana2IPC (Pentaglycosyl complex); Lane 1-3 crude
acidic fractions from C.cinereus fruiting body.
1H-NMR spectroscopy
Downfield expansions of the 1-D 1H-NMR spectra of acidic fractions 29, 30
and 31 (Figure D.2) exhibited a lone H-1 resonance at 5.045 ppm, typical for aMan of a fungal MIPC, as previously observed [30, 38, 89].
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ESI-MS analysis
The positive ion mode MS spectra of the purified GIPC fractions from the
fruiting body of C.cinereus are displayed in the figures below. The molecular ion
profiles as lithium adducts exhibited major species differing by 14 or 28 amu
consistent with lipoforms (ceramide variants) differing by one or two CH 2 units in
the sphingoid or fatty acid, or both. Other ions that are incremented by 134 or
268 amu from the major molecular ions represent lithium iodide (Lil) or (Lil2)
adducts, respectively [7]. Molecular ions were selected and subjected to MS2
analysis as follows: Fraction 29 ions at m/z 1100 and 1128 (Figure 2.7 A),
fraction 30 ions at m/z 1072 and 1086 (Figure 2.8 A) and fraction 31 ions at m/z
988 and 1016 (Figure 2.9 A). It is evident from the different MS2 results that the
differences in m/z correspond to lipoforms of MIPC. Upon subjection of the
ceramide-related [Y0+Li]+ ions at m/z 662 and 676 from fraction 30 (Figure 2.7 B
and C) to MS3 analysis (Figure D.2) both yielded identical sphingoid-related
ions at m/z 291 and 324, suggesting that fatty acids of various chain lengths and
not the sphingoid base give rise to the ceramide variants evident from the MS2
results in this fraction. This analysis has not yet been performed on fractions 29
and 31. A summary of the MS results can be found in Table 2.3 and 2.4. In my
structural characterization of GSLs from C. cinereus the main GIPC component
identified was a M a n al—>2lns1-P-1Cer. I was unable to find any GIPC with an
additional (3—Gal or other residue. TLC results and corresponding 1H-NMR data
are presented in Figure D.2. Similar results were obtained for fractions isolated
from C. cinereus mycelia (data not shown).
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Figure 2.7. A: Molecular ion profile of Fr 29 as Li adducts. B: MS2 of m/z 1100
and C: MS2 of m/z 1128.
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Figure 2.8. A: Molecular ion profile of Fr 30 as Li adducts. B: MS2 of m/z 1072
and C: MS2 of m/z 1086.
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Figure 2.9. A: Molecular ion profile of Fr 31 as Li adducts. B: MS2 of m/z 988 and
C: MS2 of m/z 1016.
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TABLES DESCRIBING FRAGMENTATION
Table 2.3: Molecular adduct ions [M(Li)+Li]+ observed in ESI-MS profile (A) and
their product ions (B) obtained from ESI-MS2 of glycosylinositol
phosphorylceramides from fruiting body of C. cinereus.
Fraction:

29

29

30

30

A. [M(Li)+Li]+:

988

1016

1072

1086

31
1100

31
1128

B.Products of [M(Li)+Li]+:

[M(Li)-Hex+Li]+

826

854

910

924

938

966

[Y0PO3 (Li)+Li]+

664

692

748

762

776

804

[Z0PO3 (Li)+Li] +

646

674

730

744

758

786

[Y0+Li] +

578

606

662

676

690

718

[Z0+Li]+

560

588

644

658

672

700

Table 2.4: Glycosylinositol ions from ESI-MS spectra of monoglycosylinositol
phosphoryceramides from fruiting body of C. cinereus.
Fragmentation designations

m/z

[C2P 0 3 (Li)+Li]+

435

[B2PO3 (Li)+Li]+

417

[C2+Li]+

349

[B2+Li]+

331
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CHAPTER III

MSn ANALYSIS OF PERMETHYLATED GLYCOSYLINOSITOLS

Introduction

In order to unambiguously determine a complete glycan structure it is
generally necessary to employ a variety of analytical techniques. Several of
these techniques require the generation and utilization of permethylated
derivatives for mass spectrometry. Permethylation confers various advantages
that are particularly useful for mass spectral characterization, the most important
of which is elimination of ambiguities with respect to linkage and branching
topology that can compromise mass spectral analysis of native samples [54]. In
addition, the hydrophobic nature of the permethylated samples makes them
amenable to organic solvent extraction procedures and often enhances signal
intensity in positive ion modes. Combining permethylation with the MSn
capabilities of ion trap MS (IT-MS) allows maximization of useful structural
information related to linkage, sequence, and in some cases monomer
stereochemistry resulting from the ions generated via glycosidic bond cleavages
and sugar ring (cross-ring) cleavages [53-55, 90-92] (Scheme 3.1).
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Scheme 3.1. Nomenclature of major fragment sugar ions are numbered from:
The reducing end for X, Y and Z and from the non-reducing end for A, B and C
ions.
I am interested in the potential of MSn for molecular dissection of
permethylated glycosylinositols (GIs) of fungal GIPCs. Application of
permethylation on intact GIPCs is limited by the base lability of the phosphate
bond, which undergoes various degrees of degradation to form by products as a
consequence of the loss of the ceramide or ceramide phosphate. To assure
complete derivatization of a single entity, the release of GIs prior to
permethylation was performed.
In Chapter II a second technique requiring permethylation, the glycosyl
linkage analysis, where methylated glycoconjugates or oligosaccharides are
hydrolysed, reduced and acetylated to generate partially methylated alditol
acetates (PMAAs), which are then analyzed by GC/MS against authentic
standards was utilized. This is the most unambiguous method for determining
linkage sites in a glycan, but generally reveals little about the actual sequence of
residues. The generation of PMAAs is also very technique and labor intensive. In
this chapter the potential use of MSn for structural characterization of
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permethylated intact glycosylinositols, where information about both sequence
and linkage topology can be obtained with considerably less sample
manipulation is shown.

Experimental Methods

Extraction and purification of GIPCs
Fungal GIPCs from various sources were extracted and purified using the
protocols described in Chapter II. The purified GIPC fractions were analyzed by
NMR and MS and structures verified using already published data [37, 40, 83].
Mass spectrometry analysis
Following the base release of GIs under high temperature and subsequent
permethylation as described previously (Chapter II) the derivatives were
subjected to positive ion mode ESI-MSn analysis. MS analysis was performed on
a quadrupole ion trap instrument (LCQ, Finnigan MAT, San Jose, CA) samples
dissolved in methanol, loaded into a 100 pL syringe attached to the electrospray
source (spray voltage = 2.0 kV, capillary temperature = 200°C, capillary voltage =
46.00 and introduced by direct infusion at a flow rate of 1.0 pL/min) or on a linear
ion trap mass spectrometer (LTQ, ThermoFinnigan, San Jose, CA), parameters
described in Ashline et al. [54].
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Results and Discussion

Positive ion mode ESI-IT-MSn of permethylated glvcosvlinositols
The behavior of permethylated GIs under the conditions of positive ion
mode MSn analysis is illustrated in the subsequent figures. As shown in Figure
3.1, the isobaric molecular ion adducts at m/z 695 are produced by isomeric
intact permethylated diglycosylinositols. Primary product ions resulting from interglycosidic bond cleavages are pyranosyl-1-ene and complementary open
hydroxyl B- and Y-type ions at m/z 241, 273, 445, 477; open hydroxyl C- type
ions are observed at m/z 259 and 463 (nomenclature suggested by Domon and
Costello) [54, 93] (Schemes 3.2 and 3.3). Complementary Z-type ions are not
abundantly observed in these spectra. The loss of a permethylated inositol
residue (250 amu) from the reducing end produces isobaric terminal
disaccharide-1-ene fragments at m/z 445. This loss is characteristic of GIs and
labels the non-reducing end glycan fragments unambiguously, unlike the case
with permethylated polyhexose oligosaccharides, from which monosaccharide
units lost form either end can produce isobaric primary fragments. The MS3
analysis of the precursor disaccharide-1-ene fragments is most important
because it gives rise to unique product ion sets for the two GIs as a consequence
of available cross-ring cleavage pathways. In Figure 3.2 B the ion at m/z 329,
and absence of m/z 315 and 371, are characteristic of a 1 —* 6 linkage (Scheme
3.2) while in Figure 3.3 B, ions at m/z 315, 343, 371 and absence of m/z 329
(Scheme 3.3), are characteristic for a 1 —> 3 linked hexose residue [54]. The
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ions at m/z 413 and 415 most likely arise from the loss of methanol and
formaldehyde, respectively.
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Figure 3.1. Positive ion mode MS1 profile of permethylated diglycosylinositol
from A: A.fumigatus GIPC M a n al—>3Mana2IPC and B: P.squamosus GIPC
Gaipi —>6Mana2IPC.
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477

FNa - MeOH = m/z 663
FNa - MeOH - CH20 = m/z 633

463

FNa+ = m/z 445
FNa+ - MeOH = m/z 413
FNa+ - MeOH - CH20 = m/z 383

Scheme 3.2. Fragmentation of m/z 695 ion produced by positive ion mode MS2
and of m/z 445 ion produced by positive ion mode MS3 of permethylated
diglycosylinositol Gal(36Mana2lns.
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Figure 3.3. Positive ion mode ESI-MSn of permethylated diglycosylinositol from
A.fumigatus GIPC M an al—>3Mana2IPC. A: MS2 product ion spectrum m/z 695
—►and B: MS3 product ion spectrum m/z 695 —►m/z 445 —
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Scheme 3.3. Fragmentation of m/z 695 ion produced by positive ion mode MS2
and of m/z 445 ion produced by positive ion mode MS3 of permethylated
diglycosylinositol Mana3Mana2lns.

As shown in Figure 3.4 the isobaric molecular ion adducts at m/z
899 are produced by isomeric intact permethylated triglycosylinositols one linear,
the other branched. The MS2 analysis of these precursor ions results in
glycosidic cleavages to produce distinct spectra Figures 3.5 A, 3.6 A; Schemes
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3.4, 3.5) Both have prominent fragments at m/z 681 (produced by loss of one
non-reducing hexose residue) and significant Y fragments at m/z 649 (loss of
inositol), but lower m/z ions reflect the different linkage topologies in the two GIs.
For example the abundant Y fragment m/z 477 and B fragment m/z 445 can only
be produced by the linear Gl (Figure 3.5 A, Scheme 3.4) The MS3 analysis of
the isobaric precursor trisaccharide-1-ene ion at m/z 649 produces a dominant
disaccharide-1-ene fragment at m/z 445 (Figure 3.5 B). A cross-ring cleavage
ion at m/z 575 consistent with a 3-linked diglycosyl fragment is also formed. As
shown in Figure 3.6 B, Scheme 3.5, the MS3 analysis of m/z 649 from the
branched trisaccharide-1-ene produces ions at m/z 413 and 431 from glycosidic
cleavages, and a cross-ring cleavage ion at m/z 371 characteristic of the loss of
the branching 1-6 linked hexose residue.
On subjection to MS4 analysis, the disaccharide-1-ene fragment at
m/z 445 undergoes cross-ring cleavages to give characteristic ions at m/z 343
and 371 (Figure 3.5C). The absence of an ion at m/z 315 eliminates the
possibility of having a 3-, 4- or 6-linked residue and suggests the presence of a
1-2 linked residue. Overall, the fragmentation pattern does not resemble those
for 3-, 4- or 6-linked disaccharide-1-enes (Ashline, Singh et al. 2005, [54] and
compare Figures 3.2, 3.3).
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Figure 3.4. Positive ion mode MS1 profile of permethylated triglycosylinositol
from A: A.nidulans GIPC Mana3(Mana6)Mana2IPC and B: A.fumigatus GIPC
M a n al—>2l\/lana1—>3Mana2IPC.
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Figure 3.5. Positive ion mode ESI-MSn of permethylated triglycosylinositol from
A.fumigatus GIPC Mana1->2Mana1—>3Mana2IPC. A: MS2 product ion spectrum
m/z 899 — B: MS3 product ion spectrum m/z 899 —►m/z 649 —> and C: MS4
product ion spectrum m/z 899 —►m/z 649 —> m/z 445 —
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Scheme 3.4. Positive ion mode fragmentation of m/z 899 ion produced by MS2,
m/z 649 ion produced by MS3, and m/z 445 ion produced by MS4 of
permethylated triglycosylinositol Mana3Mana2lns.
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Figure 3.6. Positive ion mode ESI-MSn of permethylated triglycosylinositol from
A.nidulans GIPC Mana3(Mana6)Mana2IPC. A: MS2 product ion spectrum m/z
899 —*, B: MS3 product ion spectrum m/z 899 —> m/z 649 —
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Scheme 3.5. Positive ion mode fragmentation of m/z 899 ion produced by MS2,
and m/z 649 ion produced by MS3 of permethylated triglycosylinositol
Mana3(Mana6)Mana2lns.

Applications to more complex GIs are illustrated by the next two
examples, both pentaglycosylinositols derived from basidiomycete GIPCs. (A
bisporus and C. neoformans, respectively). It is worth noting that basidiomycete
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GIPCs typically contain Gal(36Mana2IPC core; however while mushroom GIPCs
typically contain fucose and a-galactose residues, in their peripheral structures,
those of C. neoformans are characterized by a-mannose chains and a highly
distinct (B-xylose branching residue. These differences result in different
molecular weights for the permethylated inositols, sodium adducts being
observed at m/z 1277 and m/z 1263 respectively (molecular ion profile not
shown). In MS2 of the precursor ion at m/z 1277 (Figure 3.7 A), glycosidic bond
fragmentations produced ions at m/z 1089, 1059, 1027, 855 and 823 (Scheme
3.6). The MS2 analysis of the precursor ion at m/z 1263 (Figure 3.8 A) produced
a dominant ion at m/z 681 and other ions at m/z 1089, 1045, 1013, 809, 605, 477
and 431 (Scheme 3.7). A dominant isobaric ion at m/z 1089 occurring in both
spectra is consistent with the loss of a branching terminal permethylated
deoxyhexose (188 amu) (Scheme 3.6) or a branching terminal permethylated
pentose (174 amu) (Scheme 3.7) respectively, leaving isomeric
tetrahexosylinositols with one open hydroxyl each.
The MS3 analysis of the A. bisporus Gl-derived tetrasaccharide-1-ene
fragment at m/z 1027 (Figure 3.7 B, Scheme 3.6) produces an ion at m/z 911
consistent with a cross-ring cleavage. A prominent C ion is present at m/z 841.
The sequential losses of permethylated residues from the reducing terminal aid
in the assignment of the position of branching. The loss of 378 amu (204+174) is
consistent with the loss of a permethylated hexose and deoxyhexose residue.
These results confirm a Hex-O-Hex-O-Hex (OH)-O-Hex-l-ene sequence.
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The MS3 analysis of the tetrasaccharide-1-ene fragment of the C.
neoformans Gl-derived at m/z 1013 produces dominant C-type and cross-ring
cleavage ions at m/z 827 and 897 respectively (Figure 3.8 B, Scheme 3.7). Also
noticeable and distinct are ions at m/z 605 and 431. The ion at m/z 605 is
consistent with a trisaccharide-1-ene structure. Likewise the sequential loss of
residues from the reducing terminal gives rise to ions at various masses that can
be used in assigning the branching position and sequence Hex-O-Hex (OH)-OHex-0-Hex-1-ene (Scheme 3.7).

1089

A
10,59

Figure 3.7. Positive ion mode ESI-MSn of permethylated pentaglycosylinositol
from A.bisporus GIPC Gala1-»6Gala 1—>6 (Fucal—>2)Gal(31—>-6Mana2IPC. A:
MS2 product ion spectrum m/z 1277 —►and B: MS3 product ion spectrum m/z
1277 -► m/z 1277 -»• 1027^ .
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Scheme 3.6. Fragmentation of m/z 1277 ion produced by positive ion mode MS 2
and of m/z 1027 ion produced by positive ion mode MS3 of permethylated
pentaglycosylinositol Galcd—>6Gala1— > 6 (Fuca1^2)Gaipi->6M ana2IPC.
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Figure 3.8. Positive ion mode ESI-MSn of permethylated pentaglycosylinositol
from C.neoformans GIPC M a n al—>3(Xyl(31—>2) M an al—>4Gal|31—>6Mana2IPC.
A: MS2 product ion spectrum m/z 1263 —►and B: MS 3 product ion spectrum m/z
1263 —> m/z 1013 —
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MS 1 analysis of a hexaglycosylinositol derived from a still more complex
GIPC from C. neoformans was consistent with a composition similar to that of the
previous Gl, but containing one additional hexose residue, displaying a sodiated
molecular ion at m/z 1467. Figure 3.9 A yielded Y-ions at m/z 1249, 1045, 681,
and 477 (in a similar pattern to the fragmentation, of m/z 1263 but with peaks
incremented by 204 amu). Glycosidic cleavages are also observed at m/z 1043,
999, 795 and 431. The MS 3 of the hexasaccharide -1-ene fragment at m/z 1217
displayed an abundant cross-ring cleavage ion at m/z

1 1 0 1

, and a variety of

sequence defining glycosidic cleavages, as shown in Scheme 3.8.
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Figure 3.9. Positive ion mode ESI-MSn of permethylated hexaglycosylinositol
from C.neoformans GIPC M a n al—>6Mana1—>3
(Xyl|31—>-2)Mana1—>4Galf31—>6Manc(2IPC. A: MS 2 product ion spectrum m/z
1467 —> and B: MS 3 product ion spectrum m/z 1467 —►m/z 1217
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Scheme 3.8. Fragmentation of m/z 1467 ion produced by positive ion mode MS 2
and of m/z 1217 ion produced by positive ion mode MS3 of permethylated
hexaglycosylinositol Manal —>6Mana1 —>3
(Xyl(31->2)Mana1^4Gal|31^6Mana2IPC.

As shown in Figure 3.10, the MS5fragmentation pathway proceeding via
the tetrasaccharide-1-ene fragment at m/z 809 i.e. m/z 1467 —> m/z 809 —»• m/z
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635 —> m/z 445 (Scheme 3.8) yields a dominant product ion at m/z 329
consistent with a 1— > 6 linked disaccharide (compare Figure 3.2).
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Figure 3.10. Positive ion mode ESI-MSn of permethylated hexaglycosylinositol
from C.neoformans GIPC M a n al—»6Mana1—>3
(Xyl(31-»2)Mana1—>4Gal(31 —>6Mana2IPC. A: MS 4 product ion spectrum m/z 1467
—> m/z 809 —►m/z 635-» and B: MS 5 product ion spectrum m/z 1467 —» m/z 809
—►m/z 635—►m/z 445 —
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Scheme 3.9. Fragmentation of m/z 635 ion produced by positive ion mode MS 4
and of m/z 445 ion produced by positive ion mode MS 5 of permethylated
hexaglycosylinositol Manal-»6Mana1 —>3
(Xyipi —>2)Man1—>4Gal(31—>6Mana2IPC.

It is evident that MS of GIs provides information about sequence that
would complement data obtained from GC-MS linkage analysis of PMAAs.
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CHAPTER IV

METHOD DEVELOPMENT

Introduction

A variety of methodologies successfully applied to GSLs have been based
on enzymatic removal of the ceramide moiety [95-98] followed by derivatization
of the reducing glycosyl residue of the released glycan via reductive amination
[94], In the case of a major family of GSLs from plants and fungi, the
glycosylinositol phosphorylceramides (GIPCs), this strategy cannot be used.
Although chemical methods are available to release the glycosylinositol [29, 32],
the inositol residue has no aldehyde form that can be specifically derivatized this
way. Although previously applied only to mammalian GSLs, enzymatic
deacylation of the ceramide moiety using the enzyme sphingolipid ceramide Ndeacylase (SCDase) [56, 57], appeared to provide an alternative strategy that
could be applied to all GSLs, including fungal GIPCs. Preliminary experiments in
our laboratory confirmed that the enzyme has significant activity with GIPCs
(Levery SB, Eichert H, Arigi EA, unpublished).
Once the amino group of the sphingoid base has been freed, GSLs can be
coupled to any suitable amino-reactive derivatizing reagent, e.g., A/-alkyl
benzyloxycarbonyl succinimide (Cbz-OSu) and A/-hydroxysuccinimide (NHS)
esters. In my first series of experiments I utilized perfluoroalkyl tags (Scheme 4.1
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and 4.2) [99], Previous work has demonstrated the ability of fluorous
functionalized silica gel or fluorous solid phase extraction to selectively bind
fluorinated organic compounds [100-102], Fluorinated derivatives have been
used for purification of synthetic peptides and oligosaccharides, and enrichment
of peptide subsets of biological origin, with subsequent characterization by MS
[103-105], Previous unpublished work in our laboratory showed that this strategy
eliminates the problems associated with the use of bio-affinity protocols such as
biotin-captavidin-based extractions, such as inefficient recovery of derivatives
(Heather Eichert, Masters Thesis, 2005). It is furthermore compatible with a
microarray printing approach utilizing fluorine-modified glass slides as the
immobilizing surface (see Chapter V).

Ma2IPC

Ma2IPSph

Ma2IPSph

Scheme 4.1. Reaction of mannosyl IPC from with sphingolipid ceramide-A/deacylase (SCDase) and subsequent F-tagging with F-Cbz-OSu.
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Scheme 4.2. Reaction of mannosyl IPC from A. bisporus with sphingolipid
ceramide-A/-deacylase (SCDase) and subsequent F-tagging with F-Fmoc.

In my second approach I studied the use of a novel non-fluorinated
bifunctional linker NHS-PEC>2 -maleimide (succinimidyl-[(A/maleimidopropionamido)-diethyleneglycol] ester) attached first to the Ndeacylated GSL via the NHS functionality, and subsequently attached to 2mercaptoethylamine (2-MEA) via the maleimide functionality to generate a new
primary amino group for reaction with NHS-functionalized glass used for printing
of microarrays in Chapter V (Scheme 4.3). The experimental details are
described below.
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Scheme 4.3. Reaction of galactosylsphingosine (GalSph) with N HS-PE02maleimide and subsequent tagging with 2-MEA.
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Experimental Materials and Methods

A/-deacvlation of fungal G IP C s

Glycosylinositol phosphorylceramides (GIPCs) were obtained from fungal
species (A fumigatus, A. bisporus, and A. nidulans, P. squamosus) as described
[39, 40,

6 8

], De-/V-acylation was carried out with Pseudomonas sphingolipid

ceramide de-A/-acylase (SCDase) (Takara Bio, Shiga, Japan) to generate free
primary amine groups [56, 57], In general, 20mU of enzyme was added to the
sample (~20-30pg) dispersed in a biphasic environment containing 10pL buffer
(0.8% taurodeoxycholate sodium salt (TDC) in sodium acetate, pH 5.5) and 100
pL n-decane (to partition the fatty acids away from the aqueous phase since the
enzyme has reverse activity). Incubation was performed for 24 hours at 37°C
with slight agitation ( 1 0 0 rpm on a Lab-Line Environ Shaker).
Formation of Fluorocarbon derivatives and F-SPE sample cleanup
Amino-group derivatization was carried out with prototype F-Tags™
(Fluorous Technologies, Pittsburgh, PA), N-[4-(1 H,1 H,2H,2H
perfluorodecyl)benzyloxycarbonyloxyl]succinimide (F i 7 -Cbz-OSu, C 2 2 H 1 4 F 1 7 NO 5 ,
MW=695.33) (scheme 4.1) and A/-[2,7-Bis(1H,1H,2H,2H-perfluorooctyl)-9fluorenylmethoxycarbonyloxy]succinimide (F-Fmoc, C 3 5 H2 1 F2 6 NO 5 , MW=
1029.52)(Scheme 4.2) [103]. Derivatization trials were performed on
commercially available and enzymatically generated lyso-GSLs (lyso-GM1 and
galactosylsphingosine) obtained from mammals (see Appendix E for TLC
images). The resulting derivatives were separated by FluoroFlash® SPE
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cartridges, (2 grams, 8 cc tube, Fluorous Technologies Inc., Pittsburgh, PA) using
60-100% MeOH-H20 , columns pre-conditioned according to manufacturer’s
instructions.
Preparation of PBS-EDTA buffer pH 7.5
20mM Na2 HP 0 4
150mM NaCI
5mM EDTA (disodium salt: dihydrate CioHi4N208Na2.2H20 )
Preparation of NHS-PEO? maleimide and 2-Mercaptoethvlamine
A 250mM stock solution was prepared by dissolving 100mg of the
heterobifunctional linker N HS-PE02-maleimide (succinimidyl-[(A/maleimidopropionamido)-diethyleneglycol] ester) (Pierce Biotechnology, Inc.,
Rockford, IL) in 940uL of dimethylsulfoxide (DMSO) (Pierce Biotechnology, Inc.,
Rockford, IL), under conditions of minimal exposure to moisture to minimize
hydrolysis of the NHS-ester reactive group. The vial was capped under nitrogen
at -20°C. 6 mg of 2-mercaptoethylamine (2-MEA) (Pierce Biotechnology, Inc.,
Rockford, IL) was dissolved in 100pL of the reaction buffer (PBS-EDTA) pH 7.5.
NHS-PEO?-maleimide-2-MEA derivatization
100pg of lyso-GM1 was dissolved in 500pL of conjugation buffer (PBS-EDTA) pH
7.5 and 4pL of N HS-PE02-maleimide was added (Scheme 4.4). Incubation was
performed for 1hr at room temperature with slight agitation. The sample was
desalted on a Sep-PakR Vac C-18 SPE 1cc cartridge (Waters Corporation,
Milford MA) and eluted using 100% methanol. The P E 02-NHS maleimide
derivatized sample was dried down under N2, re-suspended in 100pL of buffer
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(PBS-EDTA), 10uL of the 2-MEA (above) was added and incubation done for 90
minutes at 37°C to generate a derivative with a free primary amine (Scheme
4.4). The progress of the reactions was monitored using high performance thin
layer chromatography (HPTLC) and the mass of the expected product verified
using ESI-MS and MALDI (dihydrobenzoic acid (DHB) as matrix).
HPTLC Analysis
HPTLC was performed on silica gel 60 plates (E. Merck, Darmstadt,
Germany) using chloroform/methanol/water (50:40:10 v/v/v containing 0.038%
w/v CaCh) as previously described (Chapter II).
MS Analysis
Ion trap MSn analysis was performed on a Thermo-Finnigan (San Jose,
CA) LTQ (samples introduced via direct infusion in methanol), using parameters
described in Chapter 111 and /or on a Kratos Shimadzu Axima-QIT and/or AximaCFR MALDI-TOF-MS instruments (Manchester, UK) operated in positive ion
mode, samples spotted on 10mg/mL DHB in 50% 0.01% trifluoroacetic acid
(TFA) in water and 50% acetonitrile (ACN).

Results

The relatively abundant mushroom MIPC was chosen for initial trials of the
reaction sequence (Scheme 4.1). Figure 4.1 shows the MS analysis of the
resulting F17-Cbz-OSu-lyso-Mana2IPC derivative from P. squamosus. The MS
analysis of the derivative gave the expected sodiated molecular adduct at m/z
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1346 (Figure 4.1 A), corresponding to one predominant sphingoid, t18:0 4hydroxysphinganine. The MS2 analysis gave ions consistent with the loss of part
or the entire fluorocarbon. The labels describing the fragments are shown with
corresponding m/z values in Figure 4.1 B.
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Figure 4.1. Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS2
analysis (B) of A/-deacylated G IPC (Ps-l) (Mana2IPC) Fi7-Cbz-OSu-tagged
derivative from P.squamosus.
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Figure 4.2. Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS2
analysis (B) of A/-deacylated GIPC (Ps-2) (Gal(36Mana2IPC) F17-Cbz-OSutagged derivative from P.squamosus.
A second trial with a diglycosyl-IPC from P. squamosus appeared to be
successful as well. Thus, in Figure 4.2 A, a sodiated molecular adduct at m/z
1508 corresponds to a Fi7-Cbz-OSu-lyso-Gal(36Mana2IPC derivative with an
additional hexose (m/z 1346 + 162 amu). The MS2 analysis displayed a
fragmentation pattern consistent with the formation of the expected product
(Figure 4.2 B).
Figure 4.3 A shows the HPTLC analysis of the reaction of SCDase with a
more complex GIPC, Galpa6Galpa6[Fucpa2]Gal(36Mana2IPC (BI-3) from
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Agaricus bisporus. The band in Lane 1 represents unreacted BI-3 standard. Lane
2 represents the n-decane fraction. Lane 3 represents the reaction product from
the enzymatic reaction. A shift of the orcinol stained band to a lower Rf value
(Lane 3) indicates that enzymatic A/-deacylation reaction proceeded to ~ 100%
completion. Figure 4.3 B shows the results of the subsequent F-i7 derivatization
of the A/-deacylated BI-3. Lane 1 represents the lyso-GIPC. Lanes 2 and 3
represent the derivatives eluted using 80 and 100% methanol in water
respectively. The shift of the bands back to higher Rf values is consistent with the
addition of the fluorocarbon tag. In Lane 3 the non orcinol-stained band with the
highest Rf value represents excess un-reacted tag.

A
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MM,

1 2

3

1 2

3

Figure 4.3 (A). HPTLC profile (silica gel 60, CHCl3 -MeOH-water, 50:40:10 v/v/v +
0.03% CaCh) of BI-3 from A.bisporus. Lane 1, Mana2IPC, Lane 2 Decane layer,
Lane 3 A/-deacylated GIPC (lower band). The marked band (*) does not
correspond to a GIPC. (B). HPTLC profile (silica gel 60, CHCI3 - MeOH-water,
50:40:10 v/v/v + 0.03% CaCh) of BI-3 from A.bisporus. Lane 1 A/-deacylated BI-3,
Lane 2 and 3 Fi7-derivatized BI-3 following F-SPE clean up. Fractions eluted in
80%v/v MeOH-water and 100% MeOH respectively.
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The MS analysis of the BI-3 derivative is shown in Figures 4.4 and 4.5.
The MS2 analysis of the dominant precursor ion at m/z 1978 gives rise mainly to
glycosidic cleavage ions as shown in Scheme 4.4. The MSn analysis produced
ions consistent with the loss of hexose (162 amu) and/or deoxyhexose (146 amu)
residues.
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Figure 4.4. Positive ion mode analysis ESI-LTQ-MS2 1978—> (A) and MS3
1978—>1832—»(B) analysis of A/-deacylated GIPC
Galpa6Galpa6[Fucpa2]Gal|36Mana2IPC) Fi7-Cbz-OSu-tagged derivative
following F-SPE.
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Scheme 4.4. Fragmentation scheme of F17-Cbz-OSu-derivatized BI-3 from
A.bisporus
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) product ion spectra of Ndeacylated GIPC (Galpa6Galpa6[Fucpa2]Gal|36Mana2IPC) F-i7 -Cbz-OSu-tagged
derivative.
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Derivatization with another amino group active tagging reagent, F-Fmoc
(Scheme 4.2), was carried out, again using mushroom MIPC and a dimannosyl
IPC from A. fumigatus for initial trials. As shown in Figure 4.6 A, the addition of
914 amu to the molecular mass of lyso-Mana2IPC is consistent with the
formation of the F-Fmoc-derivatized lyso-Mana2IPC. The MS profile gave a
sodiated adduct at m/z 1680 consistent with a GIPC with a t18:0 sphingoid. The
molecular ion adduct at m/z 1664 is unlikely to be a component with one less
hydroxyl group (d18:0) since this sphingoid base is not observed in the fungal
GIPC precursor. Nevertheless, in subsequent MS2 analysis, it yielded fragments
consistent with a properly derivatized GIPC. Its origin is mysterious, but under
investigation. Figure 4.6 B and C represent the MS2 analysis of precursors at
m/z 1664 and 1680, respectively, with labels describing the resulting product
ions.
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Figure 4.6. Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS2
analysis of A/-deacylated mannosyl-IPC (Mana2IPC) F-Fmoc-tagged derivative
(B and C) following F-SPE.
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Figure 4.7. Positive ion mode MALDI-QIT-TOF analysis (A) and ESI-LTQ-MS2
analysis of A/-deacylated dimannosyl-IPC (Mana3Mana2IPC) F-Fmoc-tagged
derivative (B and C) following F-SPE.
Figure 4.7 shows the MS analysis of the F-Fmoc-lyso-Mana3Mana2IPC
derivative of the dimannosyl-IPC from A.fumigatus. The sodiated molecular
adducts at m/z 1842 and 1870 are consistent with t18:0 and t20:0 sphingoid
variants known to be present in this fraction [34], The MS2 analysis of the
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precursor ions yielded fragment ions (labeled on Figure 4.7 B and C) consistent
with the expected products.
A mammalian ganglioside, lyso-GM1 was used in preliminary trials to
generate an NHS-glass compatible derivative (Scheme 4.3). The HPTLC
analysis of the reaction product of the addition of NHS-PEC>2-maleimide-2-MEA
to the amino group of lyso-GM1 is shown in Figure 4.8. The band in Lane 1
represents the underivatized lyso-GM1 standard. The shift of the band in lane 2
to a higher Rf value is consistent with a NHS-PE02-maleimide-2-MEA derivatized
lyso-GM1. The yield of the product is ~ 90%. The presence of a doublet is
consistent with a 4-sphingenine having two chain lengths, C18 and C20, i.e.
d18:1 and d20:1 sphingoids.

1 2
Figure 4.8. HPTLC profile (silica gel 60, CHCh-MeOH-water, 50:40:10 v/v/v +
0.03% CaCI2) of lyso-GM1 lane 1 and N HS-PE02-2-MEA derivatized lyso-GM1
lane 2 after C-18 SPE clean-up, sample eluted with 100% MeOH.
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Figure 4.9 A. MALDI-MS spectrum of lyso-GM1 B. lyso-GM1-PE02-maleimide
derivative and C. Lyso-GM1-PE02-maleimide-2-MEA derivative.

Scheme 4.5 represents the expected product of the reaction of lyso-GM1
with the NHS-PE02-maleimide linker. The identity of the product was confirmed
by MALDI-TOF MS; it yielded the expected predominant sodiated molecular ions
at m/z 1612 and m/z 1640, consistent with the d18:1 and d20:1 sphingoid
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variants. Di-sodiated [(Na)+Na]+ salt adducts were observed at m/z 1634 and
1662, respectively (Figure 4.9 B).
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Scheme 4.5. Structure of the expected product of the reaction of lyso-GM1 with
N HS-PE02-maleimide.

Scheme 4.6 represents the expected product of the reaction of the
addition of 2-MEA to the lyso-GM1 N HS-PE02-maleimide derivative. The identity
of the product, confirmed by MALDI-TOF MS, gave the expected predominant
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sodiated molecular ions at m/z 1690 and m/z 1718, consistent with the d18:1 and
d20:1 sphingoid variants. Corresponding [(Na)+Na]+ ions were observed at m/z
1712 and 1740 respectively (Figure 4.9 C). Comparison can be made to the
underivatized lyso-GM1 (Figure 4.9 A), with mono-sodiated ions at m/z 1302 and
1330, and disodiated ions at m/z 1324 and 1352.

H
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0
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HOOC

Scheme 4.6 Structure of the expected product of the reaction of lyso-GM1-NHSP E 0 2-maleimide derivative with 2-MEA
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Discussion

The activity of the enzyme, sphingolipid ceramide A/-deacylase (SCDase)
[56, 57], has been well characterized with respect to mammalian GSLs and
sphingomyelin, but was not previously tested with fungal GIPCs. The activity of
this enzyme with GIPCs was found to be substantially similar, sufficient to
remove the long chain 2-hydroxy fatty acid from the phytosphingosine moiety,
generally encountered in the GIPC ceramide, while leaving the glycosylinositol
phosphate moiety intact. The amino group of the resulting lyso-GIPC becomes
available for reaction with a wide variety of A/-reactive tags.
For these studies the Flourous™ fluorinated hydrocarbon (F-Tag)
methodology [103] and a novel N HS-PE02-maleimide-2-MEA linker were utilized.
The former was chosen as part of a protocol for facilitating sample cleanup by
Fluorous™ solid phase extraction (F-SPE), and immobilization of the derivatives
on fluorous glass slides. The latter was chosen as part of an alternative strategy
to facilitate sample immobilization on an /V-hydroxysuccinimide (NHS)-activated
surface (Chapter V). The N H S-PE02-maleimide-2-MEA derivative was desalted
and recovered by reverse phase C-18 solid phase extraction (C-18-SPE) in high
yield.
The “one-pot” A/-deacylation and derivatization of lyso-GSLs with
appropriate fluorocarbon tags, and their selective isolation via F-SPE, was
successfully executed. This approach minimized the loss of products associated
with the use of bio-affinity tags, the efficiency of which appeared to be reduced
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by the number of purification steps, inadequate binding to the stationary phase,
and the necessity of using highly concentrated buffers for sample release. The
use of organic solvents facilitates the subsequent direct analysis of the sample
by MS. The compatibility of the derivatives with MS strategies was confirmed by
the MS analysis of the samples.
Future developments could expand the utility of this technique to include
facilitating analysis of crude GIPC extracts, although the presence of
contaminants in the sample might interfere with the activity of the enzyme.
Therefore, optimal conditions for maintenance of the enzyme activity will need to
be evaluated. Since the alternative fluorocarbon, F-Fmoc possesses UV and
fluorescence detectability, this reagent, or one with similar properties could
potentially be used in future development of HPLC-based separation
methodologies.
Possibilities for using the affinity between F-tagged GIPCs and
fluorocarbon-modified surfaces, and the amine functionalized NHS-PEO 2 maleimide-2-MEA derivatives for covalent bond immobilization on NHS-activated
surfaces, as two potential bases for developing microarray methodologies are
discussed in Chapter V.
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CHAPTER V

DEVELOPMENT OF GLYCOSPHINGOLIPID BASED GLYCAN MICROARRAYS

Introduction

Glycosylation plays a vital role in the development, growth, functioning
and survival of organisms. Glycoconjugates mediate a variety of biological
processes, including specific recognition events within cells, on cell surfaces, in
the extracellular matrix, and in secretions, mainly via functional interactions with
endogenous or exogenous carbohydrate-binding proteins (CBPs) [106].
The interactions of glycans with proteins and other potentially interactive
molecules can be studied using microarrays of immobilized glycoconjugates.
Glycoarrays are emerging as sensitive alternative tools that speed up the study
of specific interactions between CBPs and glycans, requiring small amounts of
material and allowing rapid screening of many protein-containing samples
simultaneously. By observing the pattern of binding between an added protein
and the broad range of glycans on such an array, detailed requirements for
carbohydrate-protein interactions can be characterized, and potential candidates
for in vivo functional interactions can be identified for further experimental study.
Recent advances in glycan array manufacture involve covalent printing of
derivatized glycans onto chemically activated surfaces [107-109]. The spatial
arrangement of immobilized glycans effectively mimics their presentation on cell
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surfaces, and offers several advantages over non-covalent immobilization, such
as minimization of non-specific binding and enhancement of ligand accessibility

[110].
The successful use of fluorous-based non-covalently immobilized glycan
microarrays for studying protein-ligand binding interactions was first
demonstrated by Nicola Pohl and co-workers [111, 112]. This method has since
been used for the screening of flourous-tagged small molecules [113]. So far,
these systems have been used only with glycans having a free reducing end
whereby linkers or tags can be attached via reductive amination. This may not
fully mimic the presentation of lipid-linked glycans, and is in any case impossible
to use with GIPCs (see discussion).
In this work the efficacy of two systems for immobilization of lyso-GSLs
was studied (Scheme 5.1). For the first, I tested conventional, commercially
available amine-reactive A/-hydroxysuccinimide (NHS) glass slides employing
covalent immobilization of amine-functionalized derivatives. To facilitate this, I
developed a novel bifunctional linker assembled from commercially available
materials. For the second, I tested fluorous-coated slides for non-covalent
immobilization of fluorocarbon-tagged derivatives through fluorous-fluorous
affinity. The feasibility of these methods was tested with mammalian lysoglycolipids (lyso-GM1 ganglioside and psychosine (galactosylsphingosine)) and
lyso-GIPCs derived from fungal GIPC precursors (Chapter IV).
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Scheme 5.1. Immobilization of fluoroucarbon- and NHS-PE02-maleimide-tagged
lyso-GM1 and interaction with carbohydrate binding proteins of interest.

Experimental Materials and Methods

Printing buffer: Sodium phosphate pH 8.5
150mM of sodium phosphate buffer was prepared from a 300 mM 6X printing
buffer stock solution.
Washing buffer I: 3X PBS-Tween (PBS-~Q pH 7.5 preparation
2.5mL Tween 20
0.5 L 10X PBS
5L milli-Q water
Blocking solution
50mM ethanolamine in 50mM sodium borate pH 9.2.
Washing buffer II: PBS without tween
0.5 L 10X PBS
5L milli-Q water
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Incubation buffer: PL1-P buffer pH 7.2
29.2 g NaCI
0.2 g KCI
0.2 g KH2P 0 4
1.15 g Na 2 HP 0 4 .2 H2 0
10 g BSA
10mL Triton-X-100
Dissolved in 1L milli-Q water (pH adjusted to 7.2 using 2 drops of 1M NaOH).
Cholera toxin B (recombinant) Alexa Fluor 555 conjugate preparation
1.Omg/mL Cholera toxin B (CTX-B) (recombinant) Alexa Fluor 555 conjugate
(Molecular Probes Inc. Eugene, OR) was prepared by dissolving 100pg powder
in 0.1 mL of PBS pH 7.4 and the solution stored at 2-5°C.
PNA Lectin preparation
1mg/mL of biotinylated PNA lectin from Arachis hypogaea (peanut) (Sigma Saint
Louis, MO) dissolved in PBS pH 7.4 was diluted in the same buffer to make 2.5,
5 and 10 pg/mL solutions.
Streptavidin DvLiqht ™ 547 preparation
Streptavidin DyLight™ 547 (Pierce Biotechnology, Inc., Rockford, IL), (pink
colored liquid at a concentration of 1mg/mL in 0.1 M sodium phosphate, 0.15M
sodium chloride, pH 7.2, containing 1% BSA and 0.02% sodium azide).
Preparation of samples for printing
The fluorocarbon tagged samples were dissolved in 50% methanol in
water prior to being spotted and diluted in the same solvent to various
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concentrations viz. ~100pM, 50|jM , 25|jM , 12.5|jM , 6.25|jM and 3.125 pM. The
N HS-PE02-maleimide-2-MEA derivatives were dissolved in 150mM print buffer
and likewise diluted to the same concentrations above.
Printing of NHS-activated and fluorinated glass slides
Fluorocarbon tagged and N HS-PE02-maleimide-2-MEA derivatives were
spotted on the fluorous glass slides (Fluorous Technologies, Pittsburgh, PA) and
NHS-activated glass slides (NexterionR slide MPX 16) (Schott Nexterion, Mainz,
Germany) using a Microgrid II arrayer (Biorobotic, Cambridge, United Kingdom).
A total of six compounds were spotted onto the slides at 5 different
concentrations in replicates.
Blocking of slides
The NHS-activated slide was washed in 3X PBS-T and the buffer replaced
three times every 5 minutes in a 50ml_ Falcon tube, followed by one rinse with
milli-Q water. The slide was immersed in blocking solution and left to stand for
1hr after which it was placed in a 50% humidity chamber for 1hr. The wash steps
were repeated once more and the slide dried by centrifugation for 5 min. The
blocking step was omitted for the fluorous glass slide.
Binding assay
A silicone based superstructure supplied with the NHS-slides in a 16 well
format was used to partition the NHS-activated slide, and the appropriate
conjugate was added to the wells. In order to determine a suitable working range,
10, 5 and 2.5 pg/mL of biotin labeled PNA lectin was added to wells 2, 4 and 6
respectively, and incubation performed in the dark for 1hr. 5ug/mL of PNA lectin
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was selected as a suitable working concentration for subsequent binding
experiments. The wells were then rinsed 3 times with 100pl_ of PBS-T washing
buffer at 5 minute intervals. Incubation was done using 50pl_ of Streptavidin
DyLight™547 diluted 5000 times in PLI-P conjugation buffer was added to the
same wells. 50pL of Cholera toxin-Alexa Fluor 555 diluted 5000 times in the
same conjugation buffer added to wells 10,12 and 14 was used to perform single
step incubation. The fluorous glass slide was marked with a paraffin pen and the
conjugates added likewise using a fixed concentration of lectin (5pg/mL).
Incubation was performed in the dark for 1 hr. At the end of the incubation the
slides were washed 3 times with PBS-T and once with PBS without tween. The
slides were immersed in PBS on a slide tray before being dried down by
centrifugation.
Scanning of slides
The fluorescent images of glass slides (microarrays) were acquired using
the Array Worx Microarray Scanner (Applied Precision LLC, Issaquah WA).

Results and Discussion

The slides were probed with fluorophore-conjugated CTX and a sandwich
assay using fluororophore-conjugated streptavidin and biotinylated-PNA lectin.
The fluorescence images of the scanned glass slides are presented in Figures
5.1 and 5.2. In both slide formats, fluorescence was observed on areas where
lyso-GM1 was spotted. Lyso-GM1 appeared to remain active as a binding
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receptor for CTX. The PNA lectin, known to have a binding specificity for G aipi3GalNAc-R structures, also bound preferentially to lyso-GM1, which has the
structure Gal(31 -3GalNAc[31 -4[Neu5Aca(2,3)]Gal(31 -4GIcf31 -1 'sphingosine
(Figures 5.1 and 5.2). These results illustrate the specificity of binding to lysoGM1 by CTX and PNA lectin. Overall, the spots were reproducible in both slide
formats. There was some low background fluorescence in the unblocked fluorous
slides; however, this did not interfere with the analyte detection. The covalent
binding through amide bond formation on the NHS glass slide seemed to provide
a stronger binding efficiency than the non-covalent affinity binding on the fluorous
glass slide. The differences were evident in the ability to detect lower
concentrations of lyso-GM1 on the NHS slides compared to the fluorous slides.
Detection limits were tested in the concentration range ~100-3.125uM for the
NHS-activated slide (Figure 5.1) and ~100-25pM for the fluorous-activated slides
(Figure 5.2).
The effect of using the linker on the detection of affinity interactions was
also assessed. Since commercially available lyso-GSLs already have a free
primary amine group, I performed preliminary experiments with both derivatized
and non-derivatized lyso-GM1 on the NHS-activated slide at the same sample
concentrations. This enabled comparisons of the efficiency of binding of ligand to
the analyte, and of the analyte to the the surface, with and without the intervening
linker (Figure 5.1) to be made. The ligand binding appeared to be enhanced by
the presence of linker, consistent with increased accessibility of the glycans to
the CBPs. At this point it is unclear whether the difference in apparent binding is
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due solely to enhancement of the glycan-CBP interaction to the glass surface.
The amount (density) of GSL bound could be influenced by the presence of the
linker. More importantly, the feasibility of the immobilization of GSLs for
functional screening or identifications based on specific interactions with CBPs of
interest was demonstrated.
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Figure 5.1. Fluorescence images of GSLs arrayed on an NHS-slide. Columns of
5 spots each ~ 100, 50, 25, 12.5 and 6.25 uM incubated with cholera toxin B
(recombinant) Alexa Fluor 555 conjugate (A) and biotin labeled PNA lectinStreptavidin DyLight™ 547 conjugate (B).
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Figure 5.2. Fluorescence images of GSLs arrayed on a fluorous slide. Columns
of 3 spots each ~ 100, 50 and 25 pM incubated with cholera toxin B
(recombinant) Alexa Fluor 555 conjugate (A) and 5pg/mL of biotin labeled PNA
lectin-Streptavidin DyLight™ 547 conjugate (B).

Conclusions and Future Studies

The ability of the fluorocarbon tail (C8F i 7) and the prototype P E 0 2-NHSmaleimide-2-MEA linker to provide simple and efficient means for immobilization
of GSLs has been demonstrated. These protocols could potentially be used to
fabricate GSL-based glycan microarrays. The conditions used for generating the
derivatives appear to be substantially mild as to maintain CBP-binding structure
of the lyso-GM1, and allowed the measurement of potentially functional proteincarbohydrate interactions to be made. Since the presence of a linker enhanced
the apparent binding efficiency of the ligand, experimentation with different
linkers could be performed.
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With appropriate controls and a variety of CBPs, this protocol could be
optimized and used for screening GSLs (in the context of our project, fungal
GIPCs), where quantitative profiles could be obtained and directly related to
efficiency of glycan-protein interactions. In practice, for example, comparisons of
differential anti-GSL antibody expression patterns could be used as indicators for
various pathological states. This could lead to development of diagnostics for
conditions eliciting expression of high titers of circulating antibodies specific for
epitopes carried on GSLs. This could be applied, for example, for diagnostic
identification of fungal pathogens in cases of disseminated mycosis. The basis
for this has been suggested by studies showing reactivity of human antisera with
fungal GSLs.
Overlay immunostaining has been used to assess the reactivity of GIPCs
from the opportunistic mycopathogen A. fumigatus and non-pathogenic fungus
A. nidulans, separated on thin-layer chromatograms, against sera from a patient
with aspergillosis [34], Specific GIPC components from A. fumigatus reacted with
serum, while none from the A. nidulans appeared to be reactive. With the
growing appreciation of glycan microarrays for performing high-throughput
functional studies, we are optimistic that GSL-based glycan microarrays could be
developed using fungal GIPCs or mammalian GSLs which are immobilized and
probed with antibodies from patients’ sera. This approach would minimize the
sample size and allow parallel screening of multiple samples.
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APPENDIX A
SPHINGOLIPID BIOSYNTHETIC PATHWAY
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APPENDIX B

COMPOSITION ANALYSIS OF FATTY ACID AND SPHINGOID BASE
BY
GC/MS.
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Figure B.1. Partial total ion chromatogram of FAME
and sphingoid component analysis.
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Figure B.2. Mass spectrum of h22:0 FA M E derivative.
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Figure B.3. Mass spectrum of h23:0 FAME derivative.
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Figure B.4. Mass spectrum of h24:0 FA M E derivative.
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Fig B.5. Mass spectrum of A/-acetyl-1,3,4-tri-O-trimethylsilyl
t18:0 4-hydroxysphinganine.
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Table B.1. Interpretation of ions from GC-MS analysis of fatty acid methyl
esters.
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Figure B.6. Chromatogram of dihydroxy fatty acid (dh24:0) FAME.
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Figure B .7. M ass spectrum of dh24:0 FA M E derivative.
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Figure B.8. Partial ion chromatogram of erythro form of 2,3-dihydroxy palmitic
acid (d16:0).
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Figure B.9. Mass spectrum of erythro form of dh16:0 FAME derivative.
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Figure B.10. Partial ion chromatogram ofthreoform of 2,3-dihydroxy palmitic
acid (d16:0).
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Figure B.11. Mass spectrum ofthreoform of dh16:0 FAME derivative.
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APPENDIX C

GLYCOSYL LINKAGE ANALYSIS OF PARTIALLY METHYLATED ALDITOL
ACETATES (PMAAs) BY GC-MS.
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Figure C.1. (A) Chromatogram of FAME derivatized Ps-1 and (B) Mass
spectrum of 1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl-mannitol.
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Scheme C.2. Characteristic fragmentation of 1,5-di-0-acetyl-1-deuterio-2,3,4,(
tetra-O-methyl-mannitol.
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Figure C.2. (A) Chromatogram of FAME derivatized Ps-2 and (B) Mass
spectrum of 1,5-di-0-acetyl-1-deuterio-2,3,4,6-tetra-0-methyl-mannitol.
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Scheme C.3. Characteristic fragmentation of 1,5-di-0-acetyl-1-deuterio-2,3,4,6tetra-O-methyl-galactitol.
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Figure C.4. (A) Chromatogram of FAME derivatized Ps-5 and (B) Mass
spectrum of 1,3,5-tri-0-acetyl-1-deuterio-6-deoxy-2,4-di-0-methyl-galactitol.
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Figure C.7. Mass spectra (A) of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tetra-0methyl-mannitol and (B) of 1,5,6-tri-0-acetyl-1-deuterio-2,3,4-tetra-0-methylgalactitol.
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APPENDIX D

Coprinus cinereus SUPPLEMENTARY DATA.

142

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure D.1. HPTLC analysis of GIPC fruiting body fractions isolated from
C.cinereus corresponding to lanes 1-3 (fractions 29-31) from HPLC.
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Figure D.2. A, B and C, downfield expansions (4.00-5.60 ppm) of 1-D1H-NMR
spectra (500MHz; DMSO-cfe 2%D20; 35°C) of GIPC fruiting body fractions
isolated from C.cinereus; spectra acquired on fractions corresponding to lanes 13 (fractions 29-31) from HPLC C.cinereus (40 X 2ml fractions collected at
0.5ml/min); Lane C, crude GIPC fraction.
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Figure D.3. MS3 analysis of fraction 30: Panel A, m/z 1072—>662—►and Panel B,
m/z 1086—>676—>.
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1 2 C 3 4
Figure D.4. HPTLC (orcinol stain) of GIPCs from C.cinereus. Mobile phase
chloroform-methanol-water (50:47:14 v/v/v) containing 0.038% w/v CaCI2. Lane
C, GIPC standard containing Mana2IPC (MIPC), Lane 1-4 crude acidic fractions
from C.cinereus mycelia.

S 1 2 3 S
Figure D.5. HPTLC (orcinol stain) of neutral lipids from C.cinereus mycelia.
Mobile phase chloroform-methanol-water (60:30:5 v/v/v). Lane S, standard
containing GlcCer.
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APPENDIX E
PERMETHYLATED GLYCOSYLINOSITOLS SUPPLEMENTARY DATA.
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Figure E.1. Positive ion mode ESI-MSn of permethylated pentaglycosylinositol
from C.neoformans GIPC Maned—>3(Xylp1—>2) M an al—>-4Gal(31—>6Mana2IPC.
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Figure E.2. Positive ion mode ESI-MSn of permethylated hexaglycosylinositol
from C.neoformans GIPC M a n a l—»6Mana1—>3
(Xyipi —>2)Mana1 ->4Gal|31 —>6Mana2IPC.
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APPENDIX F

CHAPTER IV SUPPLEMENTARY DATA.
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Figure F.1. HPTLC profile (silica gel 60, CHCI3-MeOH-water, 50:40:10 v/v/v +
0.03% CaCb) of MIPC from A.bisporus. Lanes S, Mana2IPC, Lanes 1 and 3 Ndeacylated MIPC (lower band). Lanes 2 and 4 decane layer.

S 1 2 S 3 4
Figure F.2. HPTLC profile (silica gel 60, CHCh-MeOH-water, 50:40:10 v/v/v +
0.03% CaCh) of dimannosyllPC (Af-2) from A.fumigatus. Lanes S,
Mana3Mana2IPC, Lanes 1 and 3 A/-deacylated Af-2 (lower band). Lanes 2 and 4
decane layer.
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1 2 3
Figure F.3. HPTLC profile (silica gel 60, CHCl3 -MeOH-water, 50:40:10 v/v/v +
0.03% CaCfe) of lyso-GM1 lanel and F17-Cbz-OSu derivatized lyso-GM1 lanes 2
and 3.
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Figure F.4. HPTLC profile (silica gel 60, CHCI3-MeOH-water, 50:40:10 v/v/v +
0.03% CaCI2) of psychosine lanel and F17-Cbz-OSu derivatized psychosine
lanes 2 -5.
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1 2
Figure F.5. HPTLC profile (silica gel 60, CHCI3-MeOH-water, 50:40:10 v/v/v +
0.03% CaCh) of F-Fmoc derivatized lyso-GM1(40ug) lane 1 and lyso-GM1
standard lane 2.
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1 2 3 4 5 6 7 8 S
Figure F.6. HPTLC profile (silica gel 60, CHCh-MeOH-water, 50:40:10 v/v/v +
0.03% CaCI2) of F-Fmoc derivatized lyso-GMl following F-SPE clean up.
Fractions eluted in 40% v/v MeOH-H20 (Lanesland 2), 60% MeOH- H20 (lanes
3and 4), 80%v/v MeOH- H20 (lanes 5and 6), and 100% MeOH (lanes 7and 8).
Lane S is lyso-GM1 standard.
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